BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 787594 O=C(NCCCCN1CCN(CC1)c1ccccc1)N1CCN(CC1)c1ccccc1 InChI=1S/C25H35N5O/c31-25(30-21-19-29(20-22-30)24-11-5-2-6-12-24)26-13-7-8-14-27-15-17-28(18-16-27)23-9-3-1-4-10-23/h1-6,9-12H,7-8,13-22H2,(H,26,31) JEAHBVRHQWEDQL-UHFFFAOYSA-N 301779 4-Phenyl-N-(4-(4-phenylpiperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 1::US9969743, 1 D(3) dopamine receptor Human 2.00 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301779&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670892 381750521 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787595 O=C(NCCCCN1CCN(CC1)c1ccccc1)N1CCN(CC1)c1ccccc1 InChI=1S/C25H35N5O/c31-25(30-21-19-29(20-22-30)24-11-5-2-6-12-24)26-13-7-8-14-27-15-17-28(18-16-27)23-9-3-1-4-10-23/h1-6,9-12H,7-8,13-22H2,(H,26,31) JEAHBVRHQWEDQL-UHFFFAOYSA-N 301779 4-Phenyl-N-(4-(4-phenylpiperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 1::US9969743, 1 D(2) dopamine receptor Homo sapiens 124 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301779&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670892 381750521 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787596 FC(F)(F)c1cccc(c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C26H34F3N5O/c27-26(28,29)22-7-6-10-24(21-22)33-15-13-31(14-16-33)12-5-4-11-30-25(35)34-19-17-32(18-20-34)23-8-2-1-3-9-23/h1-3,6-10,21H,4-5,11-20H2,(H,30,35) PBUOIALTCUSCTG-UHFFFAOYSA-N 301786 4-Phenyl-N-(4-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 2::US9969743, 2 D(3) dopamine receptor Human 14.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301786&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670893 381750528 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787597 FC(F)(F)c1cccc(c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C26H34F3N5O/c27-26(28,29)22-7-6-10-24(21-22)33-15-13-31(14-16-33)12-5-4-11-30-25(35)34-19-17-32(18-20-34)23-8-2-1-3-9-23/h1-3,6-10,21H,4-5,11-20H2,(H,30,35) PBUOIALTCUSCTG-UHFFFAOYSA-N 301786 4-Phenyl-N-(4-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 2::US9969743, 2 D(2) dopamine receptor Homo sapiens 303 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301786&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670893 381750528 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787598 Clc1cccc(N2CCN(CCCCNC(=O)N3CCN(CC3)c3ccccc3)CC2)c1Cl InChI=1S/C25H33Cl2N5O/c26-22-9-6-10-23(24(22)27)31-15-13-29(14-16-31)12-5-4-11-28-25(33)32-19-17-30(18-20-32)21-7-2-1-3-8-21/h1-3,6-10H,4-5,11-20H2,(H,28,33) KHORMSFWFAFWPW-UHFFFAOYSA-N 301790 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 3::US9969743, 3 D(3) dopamine receptor Human 0.390 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301790&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670894 381750532 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787599 Clc1cccc(N2CCN(CCCCNC(=O)N3CCN(CC3)c3ccccc3)CC2)c1Cl InChI=1S/C25H33Cl2N5O/c26-22-9-6-10-23(24(22)27)31-15-13-29(14-16-31)12-5-4-11-28-25(33)32-19-17-30(18-20-32)21-7-2-1-3-8-21/h1-3,6-10H,4-5,11-20H2,(H,28,33) KHORMSFWFAFWPW-UHFFFAOYSA-N 301790 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 3::US9969743, 3 D(2) dopamine receptor Homo sapiens 21.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301790&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670894 381750532 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787600 FC(F)(F)c1cc(cc(c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1)C#N InChI=1S/C27H33F3N6O/c28-27(29,30)23-18-22(21-31)19-25(20-23)35-12-10-33(11-13-35)9-5-4-8-32-26(37)36-16-14-34(15-17-36)24-6-2-1-3-7-24/h1-3,6-7,18-20H,4-5,8-17H2,(H,32,37) KUNJWDFGNSXWFX-UHFFFAOYSA-N 301792 N-(4-(4-(3-Cyano-5-(trifluoromethyl)phenyl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 4::US9969743, 4 D(3) dopamine receptor Human 4.10 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301792&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670895 381750534 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787601 FC(F)(F)c1cc(cc(c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1)C#N InChI=1S/C27H33F3N6O/c28-27(29,30)23-18-22(21-31)19-25(20-23)35-12-10-33(11-13-35)9-5-4-8-32-26(37)36-16-14-34(15-17-36)24-6-2-1-3-7-24/h1-3,6-7,18-20H,4-5,8-17H2,(H,32,37) KUNJWDFGNSXWFX-UHFFFAOYSA-N 301792 N-(4-(4-(3-Cyano-5-(trifluoromethyl)phenyl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 4::US9969743, 4 D(2) dopamine receptor Homo sapiens 294 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301792&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670895 381750534 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787602 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H43N7O/c1-23-22-25(31-26(30-23)28(2,3)4)34-16-14-32(15-17-34)13-9-8-12-29-27(36)35-20-18-33(19-21-35)24-10-6-5-7-11-24/h5-7,10-11,22H,8-9,12-21H2,1-4H3,(H,29,36) ZGKBKGOWPHSOQL-UHFFFAOYSA-N 301793 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 5::US9969743, 5 D(3) dopamine receptor Human 2.70 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301793&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671053 381750535 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787603 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H43N7O/c1-23-22-25(31-26(30-23)28(2,3)4)34-16-14-32(15-17-34)13-9-8-12-29-27(36)35-20-18-33(19-21-35)24-10-6-5-7-11-24/h5-7,10-11,22H,8-9,12-21H2,1-4H3,(H,29,36) ZGKBKGOWPHSOQL-UHFFFAOYSA-N 301793 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 5::US9969743, 5 D(2) dopamine receptor Homo sapiens 366 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301793&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671053 381750535 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787604 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H43N7O/c1-23-30-25(28(2,3)4)22-26(31-23)34-16-14-32(15-17-34)13-9-8-12-29-27(36)35-20-18-33(19-21-35)24-10-6-5-7-11-24/h5-7,10-11,22H,8-9,12-21H2,1-4H3,(H,29,36) HOFUBOSPQUNORR-UHFFFAOYSA-N 301801 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 6::US9969743, 6 D(3) dopamine receptor Human 29.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301801&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671054 381750543 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787605 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H43N7O/c1-23-30-25(28(2,3)4)22-26(31-23)34-16-14-32(15-17-34)13-9-8-12-29-27(36)35-20-18-33(19-21-35)24-10-6-5-7-11-24/h5-7,10-11,22H,8-9,12-21H2,1-4H3,(H,29,36) HOFUBOSPQUNORR-UHFFFAOYSA-N 301801 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 6::US9969743, 6 D(2) dopamine receptor Homo sapiens 12888 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301801&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671054 381750543 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787606 Cc1cc(nc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C25H34F3N7O/c1-20-19-22(31-23(30-20)25(26,27)28)34-13-11-32(12-14-34)10-6-5-9-29-24(36)35-17-15-33(16-18-35)21-7-3-2-4-8-21/h2-4,7-8,19H,5-6,9-18H2,1H3,(H,29,36) HJLBJHJXDDKNRO-UHFFFAOYSA-N 301802 N-(4-(4-(6-Methyl-2-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 7::US9969743, 7 D(3) dopamine receptor Human 41.5 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301802&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671055 381750544 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787607 Cc1cc(nc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C25H34F3N7O/c1-20-19-22(31-23(30-20)25(26,27)28)34-13-11-32(12-14-34)10-6-5-9-29-24(36)35-17-15-33(16-18-35)21-7-3-2-4-8-21/h2-4,7-8,19H,5-6,9-18H2,1H3,(H,29,36) HJLBJHJXDDKNRO-UHFFFAOYSA-N 301802 N-(4-(4-(6-Methyl-2-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 7::US9969743, 7 D(2) dopamine receptor Homo sapiens 3878 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301802&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671055 381750544 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787608 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H40F3N7O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)37-15-13-35(14-16-37)12-8-7-11-32-26(39)38-19-17-36(18-20-38)22-9-5-4-6-10-22/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,32,39) XCPZHYSDOVJPIV-UHFFFAOYSA-N 301814 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 8::US9969743, 8 D(3) dopamine receptor Human 2.70 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301814&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671056 381750556 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787609 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H40F3N7O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)37-15-13-35(14-16-37)12-8-7-11-32-26(39)38-19-17-36(18-20-38)22-9-5-4-6-10-22/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,32,39) XCPZHYSDOVJPIV-UHFFFAOYSA-N 301814 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 8::US9969743, 8 D(2) dopamine receptor Homo sapiens 470 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301814&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671056 381750556 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787610 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1)C1CC1 InChI=1S/C30H45N7O/c1-30(2,3)28-32-26(24-11-12-24)23-27(33-28)36-17-15-34(16-18-36)14-8-7-13-31-29(38)37-21-19-35(20-22-37)25-9-5-4-6-10-25/h4-6,9-10,23-24H,7-8,11-22H2,1-3H3,(H,31,38) LBRSVAAYMHPXLL-UHFFFAOYSA-N 301816 N-(4-(4-(2-(tert-Butyl)-6-cyclopropylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 9::US9969743, 9 D(3) dopamine receptor Human 15.1 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301816&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671057 381750558 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787611 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1)C1CC1 InChI=1S/C30H45N7O/c1-30(2,3)28-32-26(24-11-12-24)23-27(33-28)36-17-15-34(16-18-36)14-8-7-13-31-29(38)37-21-19-35(20-22-37)25-9-5-4-6-10-25/h4-6,9-10,23-24H,7-8,11-22H2,1-3H3,(H,31,38) LBRSVAAYMHPXLL-UHFFFAOYSA-N 301816 N-(4-(4-(2-(tert-Butyl)-6-cyclopropylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 9::US9969743, 9 D(2) dopamine receptor Homo sapiens 515 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301816&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671057 381750558 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787612 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C31H49N7O/c1-30(2,3)26-24-27(34-28(33-26)31(4,5)6)37-18-16-35(17-19-37)15-11-10-14-32-29(39)38-22-20-36(21-23-38)25-12-8-7-9-13-25/h7-9,12-13,24H,10-11,14-23H2,1-6H3,(H,32,39) AQEGXNBQOSKLDA-UHFFFAOYSA-N 301821 N-(4-(4-(2,6-Di-tert-butylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 10::US9969743, 10 D(3) dopamine receptor Human 15.1 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301821&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671210 381750563 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787613 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C31H49N7O/c1-30(2,3)26-24-27(34-28(33-26)31(4,5)6)37-18-16-35(17-19-37)15-11-10-14-32-29(39)38-22-20-36(21-23-38)25-12-8-7-9-13-25/h7-9,12-13,24H,10-11,14-23H2,1-6H3,(H,32,39) AQEGXNBQOSKLDA-UHFFFAOYSA-N 301821 N-(4-(4-(2,6-Di-tert-butylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 10::US9969743, 10 D(2) dopamine receptor Homo sapiens 337 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301821&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671210 381750563 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787614 O=C(NCCCCN1CCN(CC1)c1ccnc2ccccc12)N1CCN(CC1)c1ccccc1 InChI=1S/C28H36N6O/c35-28(34-22-20-32(21-23-34)24-8-2-1-3-9-24)30-13-6-7-15-31-16-18-33(19-17-31)27-12-14-29-26-11-5-4-10-25(26)27/h1-5,8-12,14H,6-7,13,15-23H2,(H,30,35) FWRYWDVIHVFRGE-UHFFFAOYSA-N 301824 4-Phenyl-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 11::US9969743, 11 D(3) dopamine receptor Human 9.80 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301824&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671211 381750566 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787615 O=C(NCCCCN1CCN(CC1)c1ccnc2ccccc12)N1CCN(CC1)c1ccccc1 InChI=1S/C28H36N6O/c35-28(34-22-20-32(21-23-34)24-8-2-1-3-9-24)30-13-6-7-15-31-16-18-33(19-17-31)27-12-14-29-26-11-5-4-10-25(26)27/h1-5,8-12,14H,6-7,13,15-23H2,(H,30,35) FWRYWDVIHVFRGE-UHFFFAOYSA-N 301824 4-Phenyl-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 11::US9969743, 11 D(2) dopamine receptor Homo sapiens 1171 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301824&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671211 381750566 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787616 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H35ClN6O/c29-23-8-9-25-26(22-23)30-12-10-27(25)34-16-14-32(15-17-34)13-5-4-11-31-28(36)35-20-18-33(19-21-35)24-6-2-1-3-7-24/h1-3,6-10,12,22H,4-5,11,13-21H2,(H,31,36) IZROAUDTDDADJI-UHFFFAOYSA-N 301826 N-(4-(4-(7-Chloroquinolin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide (::US9598387, Compound 12::US9969743, 12 D(3) dopamine receptor Human 26.9 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301826&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671212 381750568 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787617 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C28H35ClN6O/c29-23-8-9-25-26(22-23)30-12-10-27(25)34-16-14-32(15-17-34)13-5-4-11-31-28(36)35-20-18-33(19-21-35)24-6-2-1-3-7-24/h1-3,6-10,12,22H,4-5,11,13-21H2,(H,31,36) IZROAUDTDDADJI-UHFFFAOYSA-N 301826 N-(4-(4-(7-Chloroquinolin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide (::US9598387, Compound 12::US9969743, 12 D(2) dopamine receptor Homo sapiens 933 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301826&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671212 381750568 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787618 CC(C)(C)c1nc(N2CCN(CCCCNC(=O)N3CCN(CC3)c3ccccc3)CC2)c2ccccc2n1 InChI=1S/C31H43N7O/c1-31(2,3)29-33-27-14-8-7-13-26(27)28(34-29)37-19-17-35(18-20-37)16-10-9-15-32-30(39)38-23-21-36(22-24-38)25-11-5-4-6-12-25/h4-8,11-14H,9-10,15-24H2,1-3H3,(H,32,39) AULLQWYKPQXXNM-UHFFFAOYSA-N 301827 N-(4-(4-(2-(tert-Butyl)quinazolin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 13::US9969743, 13 D(3) dopamine receptor Human 43.1 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301827&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671213 381750569 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787619 CC(C)(C)c1nc(N2CCN(CCCCNC(=O)N3CCN(CC3)c3ccccc3)CC2)c2ccccc2n1 InChI=1S/C31H43N7O/c1-31(2,3)29-33-27-14-8-7-13-26(27)28(34-29)37-19-17-35(18-20-37)16-10-9-15-32-30(39)38-23-21-36(22-24-38)25-11-5-4-6-12-25/h4-8,11-14H,9-10,15-24H2,1-3H3,(H,32,39) AULLQWYKPQXXNM-UHFFFAOYSA-N 301827 N-(4-(4-(2-(tert-Butyl)quinazolin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 13::US9969743, 13 D(2) dopamine receptor Homo sapiens 4044 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301827&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671213 381750569 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787620 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2Cl)CC1 InChI=1S/C28H39ClF3N7O/c1-27(2,3)25-34-23(28(30,31)32)20-24(35-25)38-14-12-36(13-15-38)11-7-6-10-33-26(40)39-18-16-37(17-19-39)22-9-5-4-8-21(22)29/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,33,40) SYUUHJHHENNOEK-UHFFFAOYSA-N 301828 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-chlorophenyl)piperazine-1-carboxamide ::US9598387, Compound 14::US9969743, 14 D(3) dopamine receptor Human 21.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301828&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671214 381750570 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787621 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2Cl)CC1 InChI=1S/C28H39ClF3N7O/c1-27(2,3)25-34-23(28(30,31)32)20-24(35-25)38-14-12-36(13-15-38)11-7-6-10-33-26(40)39-18-16-37(17-19-39)22-9-5-4-8-21(22)29/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,33,40) SYUUHJHHENNOEK-UHFFFAOYSA-N 301828 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-chlorophenyl)piperazine-1-carboxamide ::US9598387, Compound 14::US9969743, 14 D(2) dopamine receptor Homo sapiens 738 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301828&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671214 381750570 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787622 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(Cl)c2)CC1 InChI=1S/C28H39ClF3N7O/c1-27(2,3)25-34-23(28(30,31)32)20-24(35-25)38-13-11-36(12-14-38)10-5-4-9-33-26(40)39-17-15-37(16-18-39)22-8-6-7-21(29)19-22/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,33,40) YGLPFEUWKJCWBD-UHFFFAOYSA-N 301829 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-chlorophenyl)piperazine-1-carboxamide ::US9598387, Compound 15::US9969743, 15 D(3) dopamine receptor Human 19.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301829&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671362 381750571 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787623 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(Cl)c2)CC1 InChI=1S/C28H39ClF3N7O/c1-27(2,3)25-34-23(28(30,31)32)20-24(35-25)38-13-11-36(12-14-38)10-5-4-9-33-26(40)39-17-15-37(16-18-39)22-8-6-7-21(29)19-22/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,33,40) YGLPFEUWKJCWBD-UHFFFAOYSA-N 301829 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-chlorophenyl)piperazine-1-carboxamide ::US9598387, Compound 15::US9969743, 15 D(2) dopamine receptor Homo sapiens 582 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301829&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671362 381750571 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787624 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)c2ccc(Cl)cc2)CC1 InChI=1S/C29H40ClF3N6O/c1-28(2,3)26-35-24(29(31,32)33)20-25(36-26)38-18-16-37(17-19-38)13-5-4-12-34-27(40)39-14-10-22(11-15-39)21-6-8-23(30)9-7-21/h6-9,20,22H,4-5,10-19H2,1-3H3,(H,34,40) IBWTYJNEHLEZKF-UHFFFAOYSA-N 301830 US9598387, Compound 16::US9969743, 16 D(3) dopamine receptor Human 21.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301830&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671363 381750572 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787625 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)c2ccc(Cl)cc2)CC1 InChI=1S/C29H40ClF3N6O/c1-28(2,3)26-35-24(29(31,32)33)20-25(36-26)38-18-16-37(17-19-38)13-5-4-12-34-27(40)39-14-10-22(11-15-39)21-6-8-23(30)9-7-21/h6-9,20,22H,4-5,10-19H2,1-3H3,(H,34,40) IBWTYJNEHLEZKF-UHFFFAOYSA-N 301830 US9598387, Compound 16::US9969743, 16 D(2) dopamine receptor Homo sapiens 894 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301830&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671363 381750572 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787626 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)(C#N)c2ccccc2)CC1 InChI=1S/C30H40F3N7O/c1-28(2,3)26-36-24(30(31,32)33)21-25(37-26)39-19-17-38(18-20-39)14-8-7-13-35-27(41)40-15-11-29(22-34,12-16-40)23-9-5-4-6-10-23/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,35,41) XXUQXMYKXRYVTE-UHFFFAOYSA-N 301831 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyano-4-phenylpiperidine-1-carboxamide::US9598387, Compound 17::US9969743, 17 D(3) dopamine receptor Human 16.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301831&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671364 381750573 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787627 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)(C#N)c2ccccc2)CC1 InChI=1S/C30H40F3N7O/c1-28(2,3)26-36-24(30(31,32)33)21-25(37-26)39-19-17-38(18-20-39)14-8-7-13-35-27(41)40-15-11-29(22-34,12-16-40)23-9-5-4-6-10-23/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,35,41) XXUQXMYKXRYVTE-UHFFFAOYSA-N 301831 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyano-4-phenylpiperidine-1-carboxamide::US9598387, Compound 17::US9969743, 17 D(2) dopamine receptor Homo sapiens 843 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301831&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671364 381750573 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787628 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(Cl)c2Cl)CC1 InChI=1S/C28H38Cl2F3N7O/c1-27(2,3)25-35-22(28(31,32)33)19-23(36-25)39-13-11-37(12-14-39)10-5-4-9-34-26(41)40-17-15-38(16-18-40)21-8-6-7-20(29)24(21)30/h6-8,19H,4-5,9-18H2,1-3H3,(H,34,41) NSKAPVHFELLKGE-UHFFFAOYSA-N 301832 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2,3-dichlorophenyl)piperazine-1-carboxamide::US9598387, Compound 18::US9969743, 18 D(3) dopamine receptor Human 24.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301832&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870646 381750574 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787629 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(Cl)c2Cl)CC1 InChI=1S/C28H38Cl2F3N7O/c1-27(2,3)25-35-22(28(31,32)33)19-23(36-25)39-13-11-37(12-14-39)10-5-4-9-34-26(41)40-17-15-38(16-18-40)21-8-6-7-20(29)24(21)30/h6-8,19H,4-5,9-18H2,1-3H3,(H,34,41) NSKAPVHFELLKGE-UHFFFAOYSA-N 301832 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2,3-dichlorophenyl)piperazine-1-carboxamide::US9598387, Compound 18::US9969743, 18 D(2) dopamine receptor Homo sapiens 759 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301832&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870646 381750574 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787630 COc1ccccc1N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-15-13-36(14-16-38)12-8-7-11-33-27(40)39-19-17-37(18-20-39)22-9-5-6-10-23(22)41-4/h5-6,9-10,21H,7-8,11-20H2,1-4H3,(H,33,40) SFTJDRYGJIVCSK-UHFFFAOYSA-N 301833 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-methoxyphenyl)piperazine-1-carboxamide::US9598387, Compound 19::US9969743, 19 D(3) dopamine receptor Human 25.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301833&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117869508 381750575 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787631 COc1ccccc1N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-15-13-36(14-16-38)12-8-7-11-33-27(40)39-19-17-37(18-20-39)22-9-5-6-10-23(22)41-4/h5-6,9-10,21H,7-8,11-20H2,1-4H3,(H,33,40) SFTJDRYGJIVCSK-UHFFFAOYSA-N 301833 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-methoxyphenyl)piperazine-1-carboxamide::US9598387, Compound 19::US9969743, 19 D(2) dopamine receptor Homo sapiens 861 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301833&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117869508 381750575 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787632 COc1cccc(c1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-14-12-36(13-15-38)11-6-5-10-33-27(40)39-18-16-37(17-19-39)22-8-7-9-23(20-22)41-4/h7-9,20-21H,5-6,10-19H2,1-4H3,(H,33,40) MNPQCNYHSBXSTH-UHFFFAOYSA-N 301834 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-methoxyphenyl)piperazine-1-carboxamide::US9598387, Compound 20::US9969743, 20 D(3) dopamine receptor Human 13.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301834&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871060 381750576 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787633 COc1cccc(c1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-14-12-36(13-15-38)11-6-5-10-33-27(40)39-18-16-37(17-19-39)22-8-7-9-23(20-22)41-4/h7-9,20-21H,5-6,10-19H2,1-4H3,(H,33,40) MNPQCNYHSBXSTH-UHFFFAOYSA-N 301834 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-methoxyphenyl)piperazine-1-carboxamide::US9598387, Compound 20::US9969743, 20 D(2) dopamine receptor Homo sapiens 762 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301834&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871060 381750576 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787634 COc1ccc(cc1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-15-13-36(14-16-38)12-6-5-11-33-27(40)39-19-17-37(18-20-39)22-7-9-23(41-4)10-8-22/h7-10,21H,5-6,11-20H2,1-4H3,(H,33,40) UIWARYOQTYMMEM-UHFFFAOYSA-N 301835 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-methoxyphenyl)piperazine-1-carboxamide::US9598387, Compound 21::US9969743, 21 D(3) dopamine receptor Human 11.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301835&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870489 381750577 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787635 COc1ccc(cc1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-15-13-36(14-16-38)12-6-5-11-33-27(40)39-19-17-37(18-20-39)22-7-9-23(41-4)10-8-22/h7-10,21H,5-6,11-20H2,1-4H3,(H,33,40) UIWARYOQTYMMEM-UHFFFAOYSA-N 301835 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-methoxyphenyl)piperazine-1-carboxamide::US9598387, Compound 21::US9969743, 21 D(2) dopamine receptor Homo sapiens 557 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301835&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870489 381750577 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787636 Cc1cccc(c1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O/c1-22-8-7-9-23(20-22)37-16-18-39(19-17-37)27(40)33-10-5-6-11-36-12-14-38(15-13-36)25-21-24(29(30,31)32)34-26(35-25)28(2,3)4/h7-9,20-21H,5-6,10-19H2,1-4H3,(H,33,40) SHHFQLUNMKEEAE-UHFFFAOYSA-N 301836 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(m-tolyl)piperazine-1-carboxamide ::US9598387, Compound 22::US9969743, 22 D(3) dopamine receptor Human 24.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301836&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870393 381750578 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787637 Cc1cccc(c1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O/c1-22-8-7-9-23(20-22)37-16-18-39(19-17-37)27(40)33-10-5-6-11-36-12-14-38(15-13-36)25-21-24(29(30,31)32)34-26(35-25)28(2,3)4/h7-9,20-21H,5-6,10-19H2,1-4H3,(H,33,40) SHHFQLUNMKEEAE-UHFFFAOYSA-N 301836 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(m-tolyl)piperazine-1-carboxamide ::US9598387, Compound 22::US9969743, 22 D(2) dopamine receptor Homo sapiens 928 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301836&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870393 381750578 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787638 Cc1ccc(cc1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O/c1-22-7-9-23(10-8-22)37-17-19-39(20-18-37)27(40)33-11-5-6-12-36-13-15-38(16-14-36)25-21-24(29(30,31)32)34-26(35-25)28(2,3)4/h7-10,21H,5-6,11-20H2,1-4H3,(H,33,40) SBLISCQZPBKWHN-UHFFFAOYSA-N 301837 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(p-tolyl)piperazine-1-carboxamide ::US9598387, Compound 23::US9969743, 23 D(3) dopamine receptor Human 22.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301837&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870685 381750579 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787639 Cc1ccc(cc1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O/c1-22-7-9-23(10-8-22)37-17-19-39(20-18-37)27(40)33-11-5-6-12-36-13-15-38(16-14-36)25-21-24(29(30,31)32)34-26(35-25)28(2,3)4/h7-10,21H,5-6,11-20H2,1-4H3,(H,33,40) SBLISCQZPBKWHN-UHFFFAOYSA-N 301837 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(p-tolyl)piperazine-1-carboxamide ::US9598387, Compound 23::US9969743, 23 D(2) dopamine receptor Homo sapiens 802 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301837&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870685 381750579 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787640 CC(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(C)c2C)CC1 InChI=1S/C29H42F3N7O/c1-21(2)27-34-25(29(30,31)32)20-26(35-27)38-14-12-36(13-15-38)11-6-5-10-33-28(40)39-18-16-37(17-19-39)24-9-7-8-22(3)23(24)4/h7-9,20-21H,5-6,10-19H2,1-4H3,(H,33,40) GCWICAXLFBBMBG-UHFFFAOYSA-N 393930 US9969743, 24 D(3) dopamine receptor Human 29.9 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393930&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146047766 405264042 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787641 CC(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(C)c2C)CC1 InChI=1S/C29H42F3N7O/c1-21(2)27-34-25(29(30,31)32)20-26(35-27)38-14-12-36(13-15-38)11-6-5-10-33-28(40)39-18-16-37(17-19-39)24-9-7-8-22(3)23(24)4/h7-9,20-21H,5-6,10-19H2,1-4H3,(H,33,40) GCWICAXLFBBMBG-UHFFFAOYSA-N 393930 US9969743, 24 D(2) dopamine receptor Homo sapiens 1178 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393930&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146047766 405264042 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787642 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2C#N)CC1 InChI=1S/C29H39F3N8O/c1-28(2,3)26-35-24(29(30,31)32)20-25(36-26)39-14-12-37(13-15-39)11-7-6-10-34-27(41)40-18-16-38(17-19-40)23-9-5-4-8-22(23)21-33/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,34,41) FEBNMEHEWSKWSQ-UHFFFAOYSA-N 301839 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-cyanophenyl)piperazine-1-carboxamide::US9598387, Compound 25::US9969743, 25 D(3) dopamine receptor Human 16.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301839&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870096 381750581 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787643 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2C#N)CC1 InChI=1S/C29H39F3N8O/c1-28(2,3)26-35-24(29(30,31)32)20-25(36-26)39-14-12-37(13-15-39)11-7-6-10-34-27(41)40-18-16-38(17-19-40)23-9-5-4-8-22(23)21-33/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,34,41) FEBNMEHEWSKWSQ-UHFFFAOYSA-N 301839 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-cyanophenyl)piperazine-1-carboxamide::US9598387, Compound 25::US9969743, 25 D(2) dopamine receptor Homo sapiens 385 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301839&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870096 381750581 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787644 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(c2)C#N)CC1 InChI=1S/C29H39F3N8O/c1-28(2,3)26-35-24(29(30,31)32)20-25(36-26)39-13-11-37(12-14-39)10-5-4-9-34-27(41)40-17-15-38(16-18-40)23-8-6-7-22(19-23)21-33/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,34,41) DMJMPRBSMLSUQZ-UHFFFAOYSA-N 301840 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-cyanophenyl)piperazine-1-carboxamide ::US9598387, Compound 26::US9969743, 26 D(3) dopamine receptor Human 8.70 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301840&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870274 381750582 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787645 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(c2)C#N)CC1 InChI=1S/C29H39F3N8O/c1-28(2,3)26-35-24(29(30,31)32)20-25(36-26)39-13-11-37(12-14-39)10-5-4-9-34-27(41)40-17-15-38(16-18-40)23-8-6-7-22(19-23)21-33/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,34,41) DMJMPRBSMLSUQZ-UHFFFAOYSA-N 301840 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-cyanophenyl)piperazine-1-carboxamide ::US9598387, Compound 26::US9969743, 26 D(2) dopamine receptor Homo sapiens 707 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301840&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870274 381750582 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787646 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(c2)C(F)(F)F)CC1 InChI=1S/C29H39F6N7O/c1-27(2,3)25-37-23(29(33,34)35)20-24(38-25)41-13-11-39(12-14-41)10-5-4-9-36-26(43)42-17-15-40(16-18-42)22-8-6-7-21(19-22)28(30,31)32/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,36,43) BYQZQCQTOJRIAC-UHFFFAOYSA-N 301841 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-(trifluoromethyl)phenyl)piperazine-1-carboxamide::US9598387, Compound 27::US9969743, 27 D(3) dopamine receptor Human 29.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301841&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870063 381750583 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787647 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(c2)C(F)(F)F)CC1 InChI=1S/C29H39F6N7O/c1-27(2,3)25-37-23(29(33,34)35)20-24(38-25)41-13-11-39(12-14-41)10-5-4-9-36-26(43)42-17-15-40(16-18-42)22-8-6-7-21(19-22)28(30,31)32/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,36,43) BYQZQCQTOJRIAC-UHFFFAOYSA-N 301841 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-(trifluoromethyl)phenyl)piperazine-1-carboxamide::US9598387, Compound 27::US9969743, 27 D(2) dopamine receptor Homo sapiens 1049 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301841&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870063 381750583 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787648 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(cc2)C(F)(F)F)CC1 InChI=1S/C29H39F6N7O/c1-27(2,3)25-37-23(29(33,34)35)20-24(38-25)41-14-12-39(13-15-41)11-5-4-10-36-26(43)42-18-16-40(17-19-42)22-8-6-21(7-9-22)28(30,31)32/h6-9,20H,4-5,10-19H2,1-3H3,(H,36,43) MTNHSFFTMCIWEW-UHFFFAOYSA-N 301842 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-(trifluoromethyl)phenyl)piperazine-1-carboxamide ::US9598387, Compound 28::US9969743, 28 D(3) dopamine receptor Human 19.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301842&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870623 381750584 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787649 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(cc2)C(F)(F)F)CC1 InChI=1S/C29H39F6N7O/c1-27(2,3)25-37-23(29(33,34)35)20-24(38-25)41-14-12-39(13-15-41)11-5-4-10-36-26(43)42-18-16-40(17-19-42)22-8-6-21(7-9-22)28(30,31)32/h6-9,20H,4-5,10-19H2,1-3H3,(H,36,43) MTNHSFFTMCIWEW-UHFFFAOYSA-N 301842 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-(trifluoromethyl)phenyl)piperazine-1-carboxamide ::US9598387, Compound 28::US9969743, 28 D(2) dopamine receptor Homo sapiens 428 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301842&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870623 381750584 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787650 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccn2)CC1 InChI=1S/C27H39F3N8O/c1-26(2,3)24-33-21(27(28,29)30)20-23(34-24)37-14-12-35(13-15-37)11-7-6-10-32-25(39)38-18-16-36(17-19-38)22-8-4-5-9-31-22/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,32,39) OJCWQYKGGOVRLI-UHFFFAOYSA-N 301843 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)piperazine-1-carboxamide ::US9598387, Compound 29::US9969743, 29 D(3) dopamine receptor Human 8.00 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301843&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870055 381750585 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787651 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccn2)CC1 InChI=1S/C27H39F3N8O/c1-26(2,3)24-33-21(27(28,29)30)20-23(34-24)37-14-12-35(13-15-37)11-7-6-10-32-25(39)38-18-16-36(17-19-38)22-8-4-5-9-31-22/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,32,39) OJCWQYKGGOVRLI-UHFFFAOYSA-N 301843 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)piperazine-1-carboxamide ::US9598387, Compound 29::US9969743, 29 D(2) dopamine receptor Homo sapiens 740 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301843&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870055 381750585 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787652 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccnc2)CC1 InChI=1S/C27H39F3N8O/c1-26(2,3)24-33-22(27(28,29)30)19-23(34-24)37-13-11-35(12-14-37)10-5-4-9-32-25(39)38-17-15-36(16-18-38)21-7-6-8-31-20-21/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,32,39) CAXPEQKWERDGFO-UHFFFAOYSA-N 301844 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyridin-3-yl)piperazine-1-carboxamide ::US9598387, Compound 30::US9969743, 30 D(3) dopamine receptor Human 5.90 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301844&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871888 381750586 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787653 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccnc2)CC1 InChI=1S/C27H39F3N8O/c1-26(2,3)24-33-22(27(28,29)30)19-23(34-24)37-13-11-35(12-14-37)10-5-4-9-32-25(39)38-17-15-36(16-18-38)21-7-6-8-31-20-21/h6-8,19-20H,4-5,9-18H2,1-3H3,(H,32,39) CAXPEQKWERDGFO-UHFFFAOYSA-N 301844 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyridin-3-yl)piperazine-1-carboxamide ::US9598387, Compound 30::US9969743, 30 D(2) dopamine receptor Homo sapiens 455 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301844&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871888 381750586 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787654 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccncc2)CC1 InChI=1S/C27H39F3N8O/c1-26(2,3)24-33-22(27(28,29)30)20-23(34-24)37-14-12-35(13-15-37)11-5-4-8-32-25(39)38-18-16-36(17-19-38)21-6-9-31-10-7-21/h6-7,9-10,20H,4-5,8,11-19H2,1-3H3,(H,32,39) BGDWIZDSYFKVEK-UHFFFAOYSA-N 301845 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyridin-4-yl)piperazine-1-carboxamide::US9598387, Compound 31::US9969743, 31 D(3) dopamine receptor Human 2.60 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301845&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870360 381750587 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787655 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccncc2)CC1 InChI=1S/C27H39F3N8O/c1-26(2,3)24-33-22(27(28,29)30)20-23(34-24)37-14-12-35(13-15-37)11-5-4-8-32-25(39)38-18-16-36(17-19-38)21-6-9-31-10-7-21/h6-7,9-10,20H,4-5,8,11-19H2,1-3H3,(H,32,39) BGDWIZDSYFKVEK-UHFFFAOYSA-N 301845 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyridin-4-yl)piperazine-1-carboxamide::US9598387, Compound 31::US9969743, 31 D(2) dopamine receptor Homo sapiens 97.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301845&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870360 381750587 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787656 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ncccn2)CC1 InChI=1S/C26H38F3N9O/c1-25(2,3)22-33-20(26(27,28)29)19-21(34-22)36-13-11-35(12-14-36)10-5-4-7-32-24(39)38-17-15-37(16-18-38)23-30-8-6-9-31-23/h6,8-9,19H,4-5,7,10-18H2,1-3H3,(H,32,39) DUKWEHLCKVPDDQ-UHFFFAOYSA-N 301846 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyrimidin-2-yl)piperazine-1-carboxamide::US9598387, Compound 32::US9969743, 32 D(3) dopamine receptor Human 13.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301846&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870427 381750588 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787657 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ncccn2)CC1 InChI=1S/C26H38F3N9O/c1-25(2,3)22-33-20(26(27,28)29)19-21(34-22)36-13-11-35(12-14-36)10-5-4-7-32-24(39)38-17-15-37(16-18-38)23-30-8-6-9-31-23/h6,8-9,19H,4-5,7,10-18H2,1-3H3,(H,32,39) DUKWEHLCKVPDDQ-UHFFFAOYSA-N 301846 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyrimidin-2-yl)piperazine-1-carboxamide::US9598387, Compound 32::US9969743, 32 D(2) dopamine receptor Homo sapiens 1188 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301846&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870427 381750588 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787658 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cnccn2)CC1 InChI=1S/C26H38F3N9O/c1-25(2,3)23-33-20(26(27,28)29)18-21(34-23)36-12-10-35(11-13-36)9-5-4-6-32-24(39)38-16-14-37(15-17-38)22-19-30-7-8-31-22/h7-8,18-19H,4-6,9-17H2,1-3H3,(H,32,39) XTFGAHNJVINQAV-UHFFFAOYSA-N 301847 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyrazin-2-yl)piperazine-1-carboxamide::US9598387, Compound 33::US9969743, 33 D(3) dopamine receptor Human 8.60 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301847&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671365 381750589 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787659 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cnccn2)CC1 InChI=1S/C26H38F3N9O/c1-25(2,3)23-33-20(26(27,28)29)18-21(34-23)36-12-10-35(11-13-36)9-5-4-6-32-24(39)38-16-14-37(15-17-38)22-19-30-7-8-31-22/h7-8,18-19H,4-6,9-17H2,1-3H3,(H,32,39) XTFGAHNJVINQAV-UHFFFAOYSA-N 301847 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(pyrazin-2-yl)piperazine-1-carboxamide::US9598387, Compound 33::US9969743, 33 D(2) dopamine receptor Homo sapiens 463 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301847&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671365 381750589 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787660 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccnc3ccccc23)CC1 InChI=1S/C31H41F3N8O/c1-30(2,3)28-37-26(31(32,33)34)22-27(38-28)41-16-14-39(15-17-41)13-7-6-11-36-29(43)42-20-18-40(19-21-42)25-10-12-35-24-9-5-4-8-23(24)25/h4-5,8-10,12,22H,6-7,11,13-21H2,1-3H3,(H,36,43) HVJCLUCMUNKFOJ-UHFFFAOYSA-N 301848 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(quinolin-4-yl)piperazine-1-carboxamide::US9598387, Compound 34::US9969743, 34 D(3) dopamine receptor Human 12.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301848&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671366 381750590 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787661 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccnc3ccccc23)CC1 InChI=1S/C31H41F3N8O/c1-30(2,3)28-37-26(31(32,33)34)22-27(38-28)41-16-14-39(15-17-41)13-7-6-11-36-29(43)42-20-18-40(19-21-42)25-10-12-35-24-9-5-4-8-23(24)25/h4-5,8-10,12,22H,6-7,11,13-21H2,1-3H3,(H,36,43) HVJCLUCMUNKFOJ-UHFFFAOYSA-N 301848 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(quinolin-4-yl)piperazine-1-carboxamide::US9598387, Compound 34::US9969743, 34 D(2) dopamine receptor Homo sapiens 524 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301848&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671366 381750590 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787662 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C2CC2)CC1 InChI=1S/C25H40F3N7O/c1-24(2,3)22-30-20(25(26,27)28)18-21(31-22)34-12-10-32(11-13-34)9-5-4-8-29-23(36)35-16-14-33(15-17-35)19-6-7-19/h18-19H,4-17H2,1-3H3,(H,29,36) VTKQFQBLYNWSNR-UHFFFAOYSA-N 301849 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclopropylpiperazine-1-carboxamide ::US9598387, Compound 35::US9969743, 35 D(3) dopamine receptor Human 12.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301849&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671524 381750591 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787663 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C2CC2)CC1 InChI=1S/C25H40F3N7O/c1-24(2,3)22-30-20(25(26,27)28)18-21(31-22)34-12-10-32(11-13-34)9-5-4-8-29-23(36)35-16-14-33(15-17-35)19-6-7-19/h18-19H,4-17H2,1-3H3,(H,29,36) VTKQFQBLYNWSNR-UHFFFAOYSA-N 301849 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclopropylpiperazine-1-carboxamide ::US9598387, Compound 35::US9969743, 35 D(2) dopamine receptor Homo sapiens 331 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301849&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671524 381750591 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787664 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(Cc3ccccc3)CC2)CC1 InChI=1S/C29H42F3N7O/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-17-13-36(14-18-38)12-8-7-11-33-27(40)39-19-15-37(16-20-39)22-23-9-5-4-6-10-23/h4-6,9-10,21H,7-8,11-20,22H2,1-3H3,(H,33,40) VQJWINDRTCMVEE-UHFFFAOYSA-N 301850 4-Benzyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 36::US9969743, 36 D(3) dopamine receptor Human 16.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301850&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671525 381750592 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787665 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(Cc3ccccc3)CC2)CC1 InChI=1S/C29H42F3N7O/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)38-17-13-36(14-18-38)12-8-7-11-33-27(40)39-19-15-37(16-20-39)22-23-9-5-4-6-10-23/h4-6,9-10,21H,7-8,11-20,22H2,1-3H3,(H,33,40) VQJWINDRTCMVEE-UHFFFAOYSA-N 301850 4-Benzyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 36::US9969743, 36 D(2) dopamine receptor Homo sapiens 530 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301850&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671525 381750592 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787666 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C(=O)c2ccccc2)CC1 InChI=1S/C29H40F3N7O2/c1-28(2,3)26-34-23(29(30,31)32)21-24(35-26)37-15-13-36(14-16-37)12-8-7-11-33-27(41)39-19-17-38(18-20-39)25(40)22-9-5-4-6-10-22/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,33,41) MNHUYGGZIREYSK-UHFFFAOYSA-N 301851 4-Benzoyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 37::US9969743, 37 D(3) dopamine receptor Human 29.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301851&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671526 381750593 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787667 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C(=O)c2ccccc2)CC1 InChI=1S/C29H40F3N7O2/c1-28(2,3)26-34-23(29(30,31)32)21-24(35-26)37-15-13-36(14-16-37)12-8-7-11-33-27(41)39-19-17-38(18-20-39)25(40)22-9-5-4-6-10-22/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,33,41) MNHUYGGZIREYSK-UHFFFAOYSA-N 301851 4-Benzoyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 37::US9969743, 37 D(2) dopamine receptor Homo sapiens 998 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301851&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671526 381750593 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787668 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CC(C2)c2ccncc2)CC1 InChI=1S/C26H36F3N7O/c1-25(2,3)23-32-21(26(27,28)29)16-22(33-23)35-14-12-34(13-15-35)11-5-4-8-31-24(37)36-17-20(18-36)19-6-9-30-10-7-19/h6-7,9-10,16,20H,4-5,8,11-15,17-18H2,1-3H3,(H,31,37) MRMFTAYATXSTSO-UHFFFAOYSA-N 301852 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3-(pyridin-4-yl)azetidine-1-carboxamide ::US9598387, Compound 38::US9969743, 38 D(3) dopamine receptor Human 3.50 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301852&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671527 381750594 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787669 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CC(C2)c2ccncc2)CC1 InChI=1S/C26H36F3N7O/c1-25(2,3)23-32-21(26(27,28)29)16-22(33-23)35-14-12-34(13-15-35)11-5-4-8-31-24(37)36-17-20(18-36)19-6-9-30-10-7-19/h6-7,9-10,16,20H,4-5,8,11-15,17-18H2,1-3H3,(H,31,37) MRMFTAYATXSTSO-UHFFFAOYSA-N 301852 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3-(pyridin-4-yl)azetidine-1-carboxamide ::US9598387, Compound 38::US9969743, 38 D(2) dopamine receptor Homo sapiens 605 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301852&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671527 381750594 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787670 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2Cc3ccccc3C2)CC1 InChI=1S/C26H35F3N6O/c1-25(2,3)23-31-21(26(27,28)29)16-22(32-23)34-14-12-33(13-15-34)11-7-6-10-30-24(36)35-17-19-8-4-5-9-20(19)18-35/h4-5,8-9,16H,6-7,10-15,17-18H2,1-3H3,(H,30,36) KUAYECUROPSOMH-UHFFFAOYSA-N 301853 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)isoindoline-2-carboxamide ::US9598387, Compound 39::US9969743, 39 D(3) dopamine receptor Human 12.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301853&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671528 381750595 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787671 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2Cc3ccccc3C2)CC1 InChI=1S/C26H35F3N6O/c1-25(2,3)23-31-21(26(27,28)29)16-22(32-23)34-14-12-33(13-15-34)11-7-6-10-30-24(36)35-17-19-8-4-5-9-20(19)18-35/h4-5,8-9,16H,6-7,10-15,17-18H2,1-3H3,(H,30,36) KUAYECUROPSOMH-UHFFFAOYSA-N 301853 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)isoindoline-2-carboxamide ::US9598387, Compound 39::US9969743, 39 D(2) dopamine receptor Homo sapiens 778 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301853&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671528 381750595 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787672 COc1ccc2CN(Cc2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C27H37F3N6O2/c1-26(2,3)24-32-22(27(28,29)30)16-23(33-24)35-13-11-34(12-14-35)10-6-5-9-31-25(37)36-17-19-7-8-21(38-4)15-20(19)18-36/h7-8,15-16H,5-6,9-14,17-18H2,1-4H3,(H,31,37) GWAVQBXUVNSXRO-UHFFFAOYSA-N 301854 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-5-methoxyisoindoline-2-carboxamide ::US9598387, Compound 40::US9969743, 40 D(3) dopamine receptor Human 2.30 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301854&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671686 381750596 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787673 COc1ccc2CN(Cc2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C27H37F3N6O2/c1-26(2,3)24-32-22(27(28,29)30)16-23(33-24)35-13-11-34(12-14-35)10-6-5-9-31-25(37)36-17-19-7-8-21(38-4)15-20(19)18-36/h7-8,15-16H,5-6,9-14,17-18H2,1-4H3,(H,31,37) GWAVQBXUVNSXRO-UHFFFAOYSA-N 301854 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-5-methoxyisoindoline-2-carboxamide ::US9598387, Compound 40::US9969743, 40 D(2) dopamine receptor Homo sapiens 994 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301854&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671686 381750596 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787674 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3ccccc3C2)CC1 InChI=1S/C27H37F3N6O/c1-26(2,3)24-32-22(27(28,29)30)18-23(33-24)35-16-14-34(15-17-35)12-7-6-11-31-25(37)36-13-10-20-8-4-5-9-21(20)19-36/h4-5,8-9,18H,6-7,10-17,19H2,1-3H3,(H,31,37) QQKGKWYETGKBCS-UHFFFAOYSA-N 301855 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3,4-dihydroisoquinoline-2(1H)-carboxamide ::US9598387, Compound 41::US9969743, 41 D(3) dopamine receptor Human 22.9 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301855&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671687 381750597 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787675 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3ccccc3C2)CC1 InChI=1S/C27H37F3N6O/c1-26(2,3)24-32-22(27(28,29)30)18-23(33-24)35-16-14-34(15-17-35)12-7-6-11-31-25(37)36-13-10-20-8-4-5-9-21(20)19-36/h4-5,8-9,18H,6-7,10-17,19H2,1-3H3,(H,31,37) QQKGKWYETGKBCS-UHFFFAOYSA-N 301855 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3,4-dihydroisoquinoline-2(1H)-carboxamide ::US9598387, Compound 41::US9969743, 41 D(2) dopamine receptor Homo sapiens 490 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301855&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671687 381750597 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787676 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3ccccc3CC2)CC1 InChI=1S/C28H39F3N6O/c1-27(2,3)25-33-23(28(29,30)31)20-24(34-25)36-18-16-35(17-19-36)13-7-6-12-32-26(38)37-14-10-21-8-4-5-9-22(21)11-15-37/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,32,38) FZDNUIQNUJFKIG-UHFFFAOYSA-N 301856 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4,5-dihydro-1H-benzo[d]azepine-3(2H)-carboxamide ::US9598387, Compound 42::US9969743, 42 D(3) dopamine receptor Human 2.30 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301856&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671688 381750598 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787677 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3ccccc3CC2)CC1 InChI=1S/C28H39F3N6O/c1-27(2,3)25-33-23(28(29,30)31)20-24(34-25)36-18-16-35(17-19-36)13-7-6-12-32-26(38)37-14-10-21-8-4-5-9-22(21)11-15-37/h4-5,8-9,20H,6-7,10-19H2,1-3H3,(H,32,38) FZDNUIQNUJFKIG-UHFFFAOYSA-N 301856 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4,5-dihydro-1H-benzo[d]azepine-3(2H)-carboxamide ::US9598387, Compound 42::US9969743, 42 D(2) dopamine receptor Homo sapiens 646 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301856&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671688 381750598 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787678 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2-c2ccccc2)CC1 InChI=1S/C34H44F3N7O/c1-33(2,3)31-39-29(34(35,36)37)25-30(40-31)43-19-17-41(18-20-43)16-10-9-15-38-32(45)44-23-21-42(22-24-44)28-14-8-7-13-27(28)26-11-5-4-6-12-26/h4-8,11-14,25H,9-10,15-24H2,1-3H3,(H,38,45) BYUHWILBODEWJY-UHFFFAOYSA-N 301857 4-([1,1′-Biphenyl]-2-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 43::US9969743, 43 D(3) dopamine receptor Human 15.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301857&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671689 381750599 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787679 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2-c2ccccc2)CC1 InChI=1S/C34H44F3N7O/c1-33(2,3)31-39-29(34(35,36)37)25-30(40-31)43-19-17-41(18-20-43)16-10-9-15-38-32(45)44-23-21-42(22-24-44)28-14-8-7-13-27(28)26-11-5-4-6-12-26/h4-8,11-14,25H,9-10,15-24H2,1-3H3,(H,38,45) BYUHWILBODEWJY-UHFFFAOYSA-N 301857 4-([1,1′-Biphenyl]-2-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 43::US9969743, 43 D(2) dopamine receptor Homo sapiens 1022 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301857&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671689 381750599 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787680 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(c2)-c2ccccc2)CC1 InChI=1S/C34H44F3N7O/c1-33(2,3)31-39-29(34(35,36)37)25-30(40-31)43-18-16-41(17-19-43)15-8-7-14-38-32(45)44-22-20-42(21-23-44)28-13-9-12-27(24-28)26-10-5-4-6-11-26/h4-6,9-13,24-25H,7-8,14-23H2,1-3H3,(H,38,45) OSIFLXHIMKAMGZ-UHFFFAOYSA-N 301858 4-([1,1′-Biphenyl]-3-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 44::US9969743, 44 D(3) dopamine receptor Human 49.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301858&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671690 381750600 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787681 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cccc(c2)-c2ccccc2)CC1 InChI=1S/C34H44F3N7O/c1-33(2,3)31-39-29(34(35,36)37)25-30(40-31)43-18-16-41(17-19-43)15-8-7-14-38-32(45)44-22-20-42(21-23-44)28-13-9-12-27(24-28)26-10-5-4-6-11-26/h4-6,9-13,24-25H,7-8,14-23H2,1-3H3,(H,38,45) OSIFLXHIMKAMGZ-UHFFFAOYSA-N 301858 4-([1,1′-Biphenyl]-3-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 44::US9969743, 44 D(2) dopamine receptor Homo sapiens 1108 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301858&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671690 381750600 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787682 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(cc2)-c2ccccc2)CC1 InChI=1S/C34H44F3N7O/c1-33(2,3)31-39-29(34(35,36)37)25-30(40-31)43-19-17-41(18-20-43)16-8-7-15-38-32(45)44-23-21-42(22-24-44)28-13-11-27(12-14-28)26-9-5-4-6-10-26/h4-6,9-14,25H,7-8,15-24H2,1-3H3,(H,38,45) UFCMGCDUCCOYEK-UHFFFAOYSA-N 301859 4-([1,1′-Biphenyl]-4-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 45::US9969743, 45 D(3) dopamine receptor Human 25.1 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301859&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669215 381750601 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787683 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(cc2)-c2ccccc2)CC1 InChI=1S/C34H44F3N7O/c1-33(2,3)31-39-29(34(35,36)37)25-30(40-31)43-19-17-41(18-20-43)16-8-7-15-38-32(45)44-23-21-42(22-24-44)28-13-11-27(12-14-28)26-9-5-4-6-10-26/h4-6,9-14,25H,7-8,15-24H2,1-3H3,(H,38,45) UFCMGCDUCCOYEK-UHFFFAOYSA-N 301859 4-([1,1′-Biphenyl]-4-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide ::US9598387, Compound 45::US9969743, 45 D(2) dopamine receptor Homo sapiens 621 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301859&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669215 381750601 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787684 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)S(=O)(=O)c2ccccc2)CC1 InChI=1S/C28H43N7O3S/c1-23-22-25(31-26(30-23)28(2,3)4)33-16-14-32(15-17-33)13-9-8-12-29-27(36)34-18-20-35(21-19-34)39(37,38)24-10-6-5-7-11-24/h5-7,10-11,22H,8-9,12-21H2,1-4H3,(H,29,36) LJYNWWWADGCGMQ-UHFFFAOYSA-N 301860 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-(phenylsulfonyl)piperazine-1-carboxamide ::US9598387, Compound 46::US9969743, 46 D(3) dopamine receptor Human 31.9 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301860&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669216 381750602 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787685 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)S(=O)(=O)c2ccccc2)CC1 InChI=1S/C28H43N7O3S/c1-23-22-25(31-26(30-23)28(2,3)4)33-16-14-32(15-17-33)13-9-8-12-29-27(36)34-18-20-35(21-19-34)39(37,38)24-10-6-5-7-11-24/h5-7,10-11,22H,8-9,12-21H2,1-4H3,(H,29,36) LJYNWWWADGCGMQ-UHFFFAOYSA-N 301860 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-(phenylsulfonyl)piperazine-1-carboxamide ::US9598387, Compound 46::US9969743, 46 D(2) dopamine receptor Homo sapiens 906 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301860&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669216 381750602 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787686 Clc1cccc(N2CCN(CCCCNC(=O)N3CCC(CC3)c3ccccc3)CC2)c1Cl InChI=1S/C26H34Cl2N4O/c27-23-9-6-10-24(25(23)28)31-19-17-30(18-20-31)14-5-4-13-29-26(33)32-15-11-22(12-16-32)21-7-2-1-3-8-21/h1-3,6-10,22H,4-5,11-20H2,(H,29,33) ODFIVFUWYGFTJX-UHFFFAOYSA-N 301861 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-phenylpiperidine-1-carboxamide ::US9598387, Compound 47::US9969743, 47 D(3) dopamine receptor Human 1.90 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301861&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669217 381750603 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787687 Clc1cccc(N2CCN(CCCCNC(=O)N3CCC(CC3)c3ccccc3)CC2)c1Cl InChI=1S/C26H34Cl2N4O/c27-23-9-6-10-24(25(23)28)31-19-17-30(18-20-31)14-5-4-13-29-26(33)32-15-11-22(12-16-32)21-7-2-1-3-8-21/h1-3,6-10,22H,4-5,11-20H2,(H,29,33) ODFIVFUWYGFTJX-UHFFFAOYSA-N 301861 N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)-4-phenylpiperidine-1-carboxamide ::US9598387, Compound 47::US9969743, 47 D(2) dopamine receptor Homo sapiens 102 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301861&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669217 381750603 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787688 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)c2ccccc2)CC1 InChI=1S/C29H41F3N6O/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)37-19-17-36(18-20-37)14-8-7-13-33-27(39)38-15-11-23(12-16-38)22-9-5-4-6-10-22/h4-6,9-10,21,23H,7-8,11-20H2,1-3H3,(H,33,39) IWKLJRLAWXMABE-UHFFFAOYSA-N 301862 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperidine-1-carboxamide ::US9598387, Compound 48::US9969743, 48 D(3) dopamine receptor Human 11.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301862&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669218 381750604 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787689 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)c2ccccc2)CC1 InChI=1S/C29H41F3N6O/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)37-19-17-36(18-20-37)14-8-7-13-33-27(39)38-15-11-23(12-16-38)22-9-5-4-6-10-22/h4-6,9-10,21,23H,7-8,11-20H2,1-3H3,(H,33,39) IWKLJRLAWXMABE-UHFFFAOYSA-N 301862 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperidine-1-carboxamide ::US9598387, Compound 48::US9969743, 48 D(2) dopamine receptor Homo sapiens 1621 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301862&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669218 381750604 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787690 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(O)(CC2)c2ccccc2)CC1 InChI=1S/C29H41F3N6O2/c1-27(2,3)25-34-23(29(30,31)32)21-24(35-25)37-19-17-36(18-20-37)14-8-7-13-33-26(39)38-15-11-28(40,12-16-38)22-9-5-4-6-10-22/h4-6,9-10,21,40H,7-8,11-20H2,1-3H3,(H,33,39) AFRMZBRXLCZGJQ-UHFFFAOYSA-N 301863 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-hydroxy-4-phenylpiperidine-1-carboxamide::US9598387, Compound 49::US9969743, 49 D(3) dopamine receptor Human 27.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301863&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669219 381750605 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787691 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(O)(CC2)c2ccccc2)CC1 InChI=1S/C29H41F3N6O2/c1-27(2,3)25-34-23(29(30,31)32)21-24(35-25)37-19-17-36(18-20-37)14-8-7-13-33-26(39)38-15-11-28(40,12-16-38)22-9-5-4-6-10-22/h4-6,9-10,21,40H,7-8,11-20H2,1-3H3,(H,33,39) AFRMZBRXLCZGJQ-UHFFFAOYSA-N 301863 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-hydroxy-4-phenylpiperidine-1-carboxamide::US9598387, Compound 49::US9969743, 49 D(2) dopamine receptor Homo sapiens 1274 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301863&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669219 381750605 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787692 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(Cc3ccccc3)CC2)CC1 InChI=1S/C30H43F3N6O/c1-29(2,3)27-35-25(30(31,32)33)22-26(36-27)38-19-17-37(18-20-38)14-8-7-13-34-28(40)39-15-11-24(12-16-39)21-23-9-5-4-6-10-23/h4-6,9-10,22,24H,7-8,11-21H2,1-3H3,(H,34,40) JAOKCAPKMXUPOM-UHFFFAOYSA-N 301864 4-Benzyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperidine-1-carboxamide::US9598387, Compound 50::US9969743, 50 D(3) dopamine receptor Human 18.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301864&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669382 381750606 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787693 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(Cc3ccccc3)CC2)CC1 InChI=1S/C30H43F3N6O/c1-29(2,3)27-35-25(30(31,32)33)22-26(36-27)38-19-17-37(18-20-38)14-8-7-13-34-28(40)39-15-11-24(12-16-39)21-23-9-5-4-6-10-23/h4-6,9-10,22,24H,7-8,11-21H2,1-3H3,(H,34,40) JAOKCAPKMXUPOM-UHFFFAOYSA-N 301864 4-Benzyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperidine-1-carboxamide::US9598387, Compound 50::US9969743, 50 D(2) dopamine receptor Homo sapiens 603 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301864&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669382 381750606 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787694 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)Oc2ccccc2)CC1 InChI=1S/C29H41F3N6O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)37-19-17-36(18-20-37)14-8-7-13-33-27(39)38-15-11-23(12-16-38)40-22-9-5-4-6-10-22/h4-6,9-10,21,23H,7-8,11-20H2,1-3H3,(H,33,39) LYEPPOSVDWYIOA-UHFFFAOYSA-N 301865 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenoxypiperidine-1-carboxamide ::US9598387, Compound 51::US9969743, 51 D(3) dopamine receptor Human 44.1 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301865&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117869944 381750607 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787695 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)Oc2ccccc2)CC1 InChI=1S/C29H41F3N6O2/c1-28(2,3)26-34-24(29(30,31)32)21-25(35-26)37-19-17-36(18-20-37)14-8-7-13-33-27(39)38-15-11-23(12-16-38)40-22-9-5-4-6-10-22/h4-6,9-10,21,23H,7-8,11-20H2,1-3H3,(H,33,39) LYEPPOSVDWYIOA-UHFFFAOYSA-N 301865 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenoxypiperidine-1-carboxamide ::US9598387, Compound 51::US9969743, 51 D(2) dopamine receptor Homo sapiens 1290 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301865&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117869944 381750607 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787696 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCC(CC2)n2c3ccccc3[nH]c2=O)CC1 InChI=1S/C30H44N8O2/c1-22-21-26(34-27(32-22)30(2,3)4)36-19-17-35(18-20-36)14-8-7-13-31-28(39)37-15-11-23(12-16-37)38-25-10-6-5-9-24(25)33-29(38)40/h5-6,9-10,21,23H,7-8,11-20H2,1-4H3,(H,31,39)(H,33,40) OCVVZZUNABZIKS-UHFFFAOYSA-N 301866 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-1-carboxamide::US9598387, Compound 52::US9969743, 52 D(3) dopamine receptor Human 7.30 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301866&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669383 381750608 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787697 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCC(CC2)n2c3ccccc3[nH]c2=O)CC1 InChI=1S/C30H44N8O2/c1-22-21-26(34-27(32-22)30(2,3)4)36-19-17-35(18-20-36)14-8-7-13-31-28(39)37-15-11-23(12-16-37)38-25-10-6-5-9-24(25)33-29(38)40/h5-6,9-10,21,23H,7-8,11-20H2,1-4H3,(H,31,39)(H,33,40) OCVVZZUNABZIKS-UHFFFAOYSA-N 301866 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-1-carboxamide::US9598387, Compound 52::US9969743, 52 D(2) dopamine receptor Homo sapiens 680 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301866&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669383 381750608 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787698 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)n2c3ccccc3[nH]c2=O)CC1 InChI=1S/C30H41F3N8O2/c1-29(2,3)26-36-24(30(31,32)33)20-25(37-26)39-18-16-38(17-19-39)13-7-6-12-34-27(42)40-14-10-21(11-15-40)41-23-9-5-4-8-22(23)35-28(41)43/h4-5,8-9,20-21H,6-7,10-19H2,1-3H3,(H,34,42)(H,35,43) WZPFDUCGTCDHML-UHFFFAOYSA-N 301867 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-1-carboxamide::US9598387, Compound 53::US9969743, 53 D(3) dopamine receptor Human 35.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301867&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669384 381750609 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787699 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)n2c3ccccc3[nH]c2=O)CC1 InChI=1S/C30H41F3N8O2/c1-29(2,3)26-36-24(30(31,32)33)20-25(37-26)39-18-16-38(17-19-39)13-7-6-12-34-27(42)40-14-10-21(11-15-40)41-23-9-5-4-8-22(23)35-28(41)43/h4-5,8-9,20-21H,6-7,10-19H2,1-3H3,(H,34,42)(H,35,43) WZPFDUCGTCDHML-UHFFFAOYSA-N 301867 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidine-1-carboxamide::US9598387, Compound 53::US9969743, 53 D(2) dopamine receptor Homo sapiens 713 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301867&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669384 381750609 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787700 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(cc4c3C2)C#N)CC1 InChI=1S/C30H37F3N8O/c1-29(2,3)27-37-25(30(31,32)33)17-26(38-27)40-14-12-39(13-15-40)10-5-4-9-35-28(42)41-11-8-24-22(19-41)21-16-20(18-34)6-7-23(21)36-24/h6-7,16-17,36H,4-5,8-15,19H2,1-3H3,(H,35,42) MCHYZZVQJHNDSP-UHFFFAOYSA-N 301868 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-cyano-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 54::US9969743, 54 D(3) dopamine receptor Human 40.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301868&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669385 381750610 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787701 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(cc4c3C2)C#N)CC1 InChI=1S/C30H37F3N8O/c1-29(2,3)27-37-25(30(31,32)33)17-26(38-27)40-14-12-39(13-15-40)10-5-4-9-35-28(42)41-11-8-24-22(19-41)21-16-20(18-34)6-7-23(21)36-24/h6-7,16-17,36H,4-5,8-15,19H2,1-3H3,(H,35,42) MCHYZZVQJHNDSP-UHFFFAOYSA-N 301868 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-cyano-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 54::US9969743, 54 D(2) dopamine receptor Homo sapiens 1046 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301868&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669385 381750610 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787702 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1 InChI=1S/C29H38F3N7O/c1-28(2,3)26-35-24(29(30,31)32)18-25(36-26)38-16-14-37(15-17-38)12-7-6-11-33-27(40)39-13-10-21-20-8-4-5-9-22(20)34-23(21)19-39/h4-5,8-9,18,34H,6-7,10-17,19H2,1-3H3,(H,33,40) JWWLBNFBBLUIHS-UHFFFAOYSA-N 393961 US9969743, 55 D(3) dopamine receptor Human 3.00 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393961&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490688 405264073 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787703 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1 InChI=1S/C29H38F3N7O/c1-28(2,3)26-35-24(29(30,31)32)18-25(36-26)38-16-14-37(15-17-38)12-7-6-11-33-27(40)39-13-10-21-20-8-4-5-9-22(20)34-23(21)19-39/h4-5,8-9,18,34H,6-7,10-17,19H2,1-3H3,(H,33,40) JWWLBNFBBLUIHS-UHFFFAOYSA-N 393961 US9969743, 55 D(2) dopamine receptor Homo sapiens 536 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393961&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490688 405264073 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787704 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1 InChI=1S/C32H47N7O/c1-31(2,3)27-21-28(36-29(35-27)32(4,5)6)38-19-17-37(18-20-38)15-10-9-14-33-30(40)39-16-13-24-23-11-7-8-12-25(23)34-26(24)22-39/h7-8,11-12,21,34H,9-10,13-20,22H2,1-6H3,(H,33,40) UTWPJLLDBXANCC-UHFFFAOYSA-N 393962 US9969743, 56 D(3) dopamine receptor Human 9.50 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393962&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490687 405264074 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787705 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1 InChI=1S/C32H47N7O/c1-31(2,3)27-21-28(36-29(35-27)32(4,5)6)38-19-17-37(18-20-38)15-10-9-14-33-30(40)39-16-13-24-23-11-7-8-12-25(23)34-26(24)22-39/h7-8,11-12,21,34H,9-10,13-20,22H2,1-6H3,(H,33,40) UTWPJLLDBXANCC-UHFFFAOYSA-N 393962 US9969743, 56 D(2) dopamine receptor Homo sapiens 308 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393962&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490687 405264074 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787706 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(Cl)cc2)CC1 InChI=1S/C28H39ClF3N7O/c1-27(2,3)25-34-23(28(30,31)32)20-24(35-25)38-14-12-36(13-15-38)11-5-4-10-33-26(40)39-18-16-37(17-19-39)22-8-6-21(29)7-9-22/h6-9,20H,4-5,10-19H2,1-3H3,(H,33,40) VGARNUPXALCIJC-UHFFFAOYSA-N 301871 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-chlorophenyl)piperazine-1-carboxamide::US9598387, Compound 57::US9969743, 57 D(3) dopamine receptor Human 35.5 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301871&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669551 381750613 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787707 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(Cl)cc2)CC1 InChI=1S/C28H39ClF3N7O/c1-27(2,3)25-34-23(28(30,31)32)20-24(35-25)38-14-12-36(13-15-38)11-5-4-10-33-26(40)39-18-16-37(17-19-39)22-8-6-21(29)7-9-22/h6-9,20H,4-5,10-19H2,1-3H3,(H,33,40) VGARNUPXALCIJC-UHFFFAOYSA-N 301871 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-chlorophenyl)piperazine-1-carboxamide::US9598387, Compound 57::US9969743, 57 D(2) dopamine receptor Homo sapiens 644 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301871&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669551 381750613 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787708 Cc1ccccc1N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O/c1-22-9-5-6-10-23(22)37-17-19-39(20-18-37)27(40)33-11-7-8-12-36-13-15-38(16-14-36)25-21-24(29(30,31)32)34-26(35-25)28(2,3)4/h5-6,9-10,21H,7-8,11-20H2,1-4H3,(H,33,40) FPUAKJDDMRFFBU-UHFFFAOYSA-N 301872 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(o-tolyl)piperazine-1-carboxamide ::US9598387, Compound 58::US9969743, 58 D(3) dopamine receptor Human 70.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301872&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669552 381750614 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787709 Cc1ccccc1N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C29H42F3N7O/c1-22-9-5-6-10-23(22)37-17-19-39(20-18-37)27(40)33-11-7-8-12-36-13-15-38(16-14-36)25-21-24(29(30,31)32)34-26(35-25)28(2,3)4/h5-6,9-10,21H,7-8,11-20H2,1-4H3,(H,33,40) FPUAKJDDMRFFBU-UHFFFAOYSA-N 301872 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(o-tolyl)piperazine-1-carboxamide ::US9598387, Compound 58::US9969743, 58 D(2) dopamine receptor Homo sapiens 789 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301872&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669552 381750614 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787710 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(cc2)C#N)CC1 InChI=1S/C29H39F3N8O/c1-28(2,3)26-35-24(29(30,31)32)20-25(36-26)39-14-12-37(13-15-39)11-5-4-10-34-27(41)40-18-16-38(17-19-40)23-8-6-22(21-33)7-9-23/h6-9,20H,4-5,10-19H2,1-3H3,(H,34,41) COMHXTZJQDZANW-UHFFFAOYSA-N 301873 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-cyanophenyl)piperazine-1-carboxamide ::US9598387, Compound 59::US9969743, 59 D(3) dopamine receptor Human 19.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301873&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669553 381750615 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787711 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(cc2)C#N)CC1 InChI=1S/C29H39F3N8O/c1-28(2,3)26-35-24(29(30,31)32)20-25(36-26)39-14-12-37(13-15-39)11-5-4-10-34-27(41)40-18-16-38(17-19-40)23-8-6-22(21-33)7-9-23/h6-9,20H,4-5,10-19H2,1-3H3,(H,34,41) COMHXTZJQDZANW-UHFFFAOYSA-N 301873 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-cyanophenyl)piperazine-1-carboxamide ::US9598387, Compound 59::US9969743, 59 D(2) dopamine receptor Homo sapiens 342 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301873&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669553 381750615 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787712 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(Cl)c(Cl)c2)CC1 InChI=1S/C28H38Cl2F3N7O/c1-27(2,3)25-35-23(28(31,32)33)19-24(36-25)39-12-10-37(11-13-39)9-5-4-8-34-26(41)40-16-14-38(15-17-40)20-6-7-21(29)22(30)18-20/h6-7,18-19H,4-5,8-17H2,1-3H3,(H,34,41) VQAXSIOYACBCCS-UHFFFAOYSA-N 301874 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3,4-dichlorophenyl)piperazine-1-carboxamide::US9598387, Compound 60::US9969743, 60 D(3) dopamine receptor Human 46.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301874&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669554 381750616 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787713 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccc(Cl)c(Cl)c2)CC1 InChI=1S/C28H38Cl2F3N7O/c1-27(2,3)25-35-23(28(31,32)33)19-24(36-25)39-12-10-37(11-13-39)9-5-4-8-34-26(41)40-16-14-38(15-17-40)20-6-7-21(29)22(30)18-20/h6-7,18-19H,4-5,8-17H2,1-3H3,(H,34,41) VQAXSIOYACBCCS-UHFFFAOYSA-N 301874 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3,4-dichlorophenyl)piperazine-1-carboxamide::US9598387, Compound 60::US9969743, 60 D(2) dopamine receptor Homo sapiens 570 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301874&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669554 381750616 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787714 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cc(cc(c2)C(F)(F)F)C#N)CC1 InChI=1S/C30H38F6N8O/c1-28(2,3)26-39-24(30(34,35)36)19-25(40-26)43-10-8-41(9-11-43)7-5-4-6-38-27(45)44-14-12-42(13-15-44)23-17-21(20-37)16-22(18-23)29(31,32)33/h16-19H,4-15H2,1-3H3,(H,38,45) VZWLMLULZYPQLO-UHFFFAOYSA-N 301875 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-cyano-5-(trifluoromethyl)phenyl)piperazine-1-carboxamide::US9598387, Compound 61::US9969743, 61 D(3) dopamine receptor Human 48.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301875&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669714 381750617 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787715 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cc(cc(c2)C(F)(F)F)C#N)CC1 InChI=1S/C30H38F6N8O/c1-28(2,3)26-39-24(30(34,35)36)19-25(40-26)43-10-8-41(9-11-43)7-5-4-6-38-27(45)44-14-12-42(13-15-44)23-17-21(20-37)16-22(18-23)29(31,32)33/h16-19H,4-15H2,1-3H3,(H,38,45) VZWLMLULZYPQLO-UHFFFAOYSA-N 301875 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-cyano-5-(trifluoromethyl)phenyl)piperazine-1-carboxamide::US9598387, Compound 61::US9969743, 61 D(2) dopamine receptor Homo sapiens 896 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301875&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669714 381750617 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787716 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cc(nc(n2)C(C)(C)C)C(F)(F)F)CC1 InChI=1S/C31H45F6N9O/c1-28(2,3)25-39-21(30(32,33)34)19-23(41-25)44-13-11-43(12-14-44)10-8-7-9-38-27(47)46-17-15-45(16-18-46)24-20-22(31(35,36)37)40-26(42-24)29(4,5)6/h19-20H,7-18H2,1-6H3,(H,38,47) BZSXKGCWTZRLML-UHFFFAOYSA-N 301876 4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 62::US9969743, 62 D(3) dopamine receptor Human 106 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301876&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669715 381750618 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787717 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2cc(nc(n2)C(C)(C)C)C(F)(F)F)CC1 InChI=1S/C31H45F6N9O/c1-28(2,3)25-39-21(30(32,33)34)19-23(41-25)44-13-11-43(12-14-44)10-8-7-9-38-27(47)46-17-15-45(16-18-46)24-20-22(31(35,36)37)40-26(42-24)29(4,5)6/h19-20H,7-18H2,1-6H3,(H,38,47) BZSXKGCWTZRLML-UHFFFAOYSA-N 301876 4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 62::US9969743, 62 D(2) dopamine receptor Homo sapiens 1519 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301876&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669715 381750618 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787718 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccnc3cc(Cl)ccc23)CC1 InChI=1S/C31H40ClF3N8O/c1-30(2,3)28-38-26(31(33,34)35)21-27(39-28)42-14-12-40(13-15-42)11-5-4-9-37-29(44)43-18-16-41(17-19-43)25-8-10-36-24-20-22(32)6-7-23(24)25/h6-8,10,20-21H,4-5,9,11-19H2,1-3H3,(H,37,44) RNKUEZGSYUCLKY-UHFFFAOYSA-N 301877 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(7-chloroquinolin-4-yl)piperazine-1-carboxamide ::US9598387, Compound 63::US9969743, 63 D(3) dopamine receptor Human 19.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301877&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669716 381750619 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787719 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccnc3cc(Cl)ccc23)CC1 InChI=1S/C31H40ClF3N8O/c1-30(2,3)28-38-26(31(33,34)35)21-27(39-28)42-14-12-40(13-15-42)11-5-4-9-37-29(44)43-18-16-41(17-19-43)25-8-10-36-24-20-22(32)6-7-23(24)25/h6-8,10,20-21H,4-5,9,11-19H2,1-3H3,(H,37,44) RNKUEZGSYUCLKY-UHFFFAOYSA-N 301877 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(7-chloroquinolin-4-yl)piperazine-1-carboxamide ::US9598387, Compound 63::US9969743, 63 D(2) dopamine receptor Homo sapiens 359 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301877&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669716 381750619 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787720 CN1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C23H38F3N7O/c1-22(2,3)20-28-18(23(24,25)26)17-19(29-20)32-15-11-31(12-16-32)8-6-5-7-27-21(34)33-13-9-30(4)10-14-33/h17H,5-16H2,1-4H3,(H,27,34) ZAVVYZJMZVTMNK-UHFFFAOYSA-N 301878 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-methylpiperazine-1-carboxamide ::US9598387, Compound 64::US9969743, 64 D(3) dopamine receptor Human 9.80 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301878&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669717 381750620 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787721 CN1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C23H38F3N7O/c1-22(2,3)20-28-18(23(24,25)26)17-19(29-20)32-15-11-31(12-16-32)8-6-5-7-27-21(34)33-13-9-30(4)10-14-33/h17H,5-16H2,1-4H3,(H,27,34) ZAVVYZJMZVTMNK-UHFFFAOYSA-N 301878 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-methylpiperazine-1-carboxamide ::US9598387, Compound 64::US9969743, 64 D(2) dopamine receptor Homo sapiens 167 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301878&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669717 381750620 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787722 CCN1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C24H40F3N7O/c1-5-31-10-16-34(17-11-31)22(35)28-8-6-7-9-32-12-14-33(15-13-32)20-18-19(24(25,26)27)29-21(30-20)23(2,3)4/h18H,5-17H2,1-4H3,(H,28,35) IDMCBMOPQUHSKE-UHFFFAOYSA-N 301879 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-ethylpiperazine-1-carboxamide::US9598387, Compound 65::US9969743, 65 D(3) dopamine receptor Human 8.60 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301879&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669718 381750621 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787723 CCN1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C24H40F3N7O/c1-5-31-10-16-34(17-11-31)22(35)28-8-6-7-9-32-12-14-33(15-13-32)20-18-19(24(25,26)27)29-21(30-20)23(2,3)4/h18H,5-17H2,1-4H3,(H,28,35) IDMCBMOPQUHSKE-UHFFFAOYSA-N 301879 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-ethylpiperazine-1-carboxamide::US9598387, Compound 65::US9969743, 65 D(2) dopamine receptor Homo sapiens 128 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301879&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669718 381750621 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787724 CC(C)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)C)C(F)(F)F InChI=1S/C24H40F3N7O/c1-18(2)22-29-20(24(25,26)27)17-21(30-22)33-11-9-31(10-12-33)8-6-5-7-28-23(35)34-15-13-32(14-16-34)19(3)4/h17-19H,5-16H2,1-4H3,(H,28,35) WXIJHIYOSNRVJO-UHFFFAOYSA-N 301881 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-isopropylpiperazine-1-carboxamide ::US9598387, Compound 66::US9969743, 66 D(3) dopamine receptor Human 9.60 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301881&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 137554067 381750623 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787725 CC(C)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)C)C(F)(F)F InChI=1S/C24H40F3N7O/c1-18(2)22-29-20(24(25,26)27)17-21(30-22)33-11-9-31(10-12-33)8-6-5-7-28-23(35)34-15-13-32(14-16-34)19(3)4/h17-19H,5-16H2,1-4H3,(H,28,35) WXIJHIYOSNRVJO-UHFFFAOYSA-N 301881 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-isopropylpiperazine-1-carboxamide ::US9598387, Compound 66::US9969743, 66 D(2) dopamine receptor Homo sapiens 125 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301881&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 137554067 381750623 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787726 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2Cc2ccccc2)C2CC2)CC1 InChI=1S/C32H46F3N7O/c1-31(2,3)29-37-27(32(33,34)35)22-28(38-29)40-17-15-39(16-18-40)14-8-7-13-36-30(43)42-20-19-41(25-11-12-25)23-26(42)21-24-9-5-4-6-10-24/h4-6,9-10,22,25-26H,7-8,11-21,23H2,1-3H3,(H,36,43) NJUHOBFYJCKTIZ-UHFFFAOYSA-N 301882 2-Benzyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclopropylpiperazine-1-carboxamide ::US9598387, Compound 67::US9969743, 67 D(3) dopamine receptor Human 73.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301882&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669892 381750624 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787727 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2Cc2ccccc2)C2CC2)CC1 InChI=1S/C32H46F3N7O/c1-31(2,3)29-37-27(32(33,34)35)22-28(38-29)40-17-15-39(16-18-40)14-8-7-13-36-30(43)42-20-19-41(25-11-12-25)23-26(42)21-24-9-5-4-6-10-24/h4-6,9-10,22,25-26H,7-8,11-21,23H2,1-3H3,(H,36,43) NJUHOBFYJCKTIZ-UHFFFAOYSA-N 301882 2-Benzyl-N-(4-(4-(2-(tert-butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclopropylpiperazine-1-carboxamide ::US9598387, Compound 67::US9969743, 67 D(2) dopamine receptor Homo sapiens 626 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301882&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669892 381750624 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787728 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC3CC3)CC2)CC1 InChI=1S/C26H42F3N7O/c1-25(2,3)23-31-21(26(27,28)29)18-22(32-23)35-14-10-33(11-15-35)9-5-4-8-30-24(37)36-16-12-34(13-17-36)19-20-6-7-20/h18,20H,4-17,19H2,1-3H3,(H,30,37) RASUXNNRRRIRBL-UHFFFAOYSA-N 301883 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(cyclopropylmethyl)piperazine-1-carboxamide ::US9598387, Compound 68::US9969743, 68 D(3) dopamine receptor Human 13.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301883&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669893 381750625 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787729 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC3CC3)CC2)CC1 InChI=1S/C26H42F3N7O/c1-25(2,3)23-31-21(26(27,28)29)18-22(32-23)35-14-10-33(11-15-35)9-5-4-8-30-24(37)36-16-12-34(13-17-36)19-20-6-7-20/h18,20H,4-17,19H2,1-3H3,(H,30,37) RASUXNNRRRIRBL-UHFFFAOYSA-N 301883 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(cyclopropylmethyl)piperazine-1-carboxamide ::US9598387, Compound 68::US9969743, 68 D(2) dopamine receptor Homo sapiens 184 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301883&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669893 381750625 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787730 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C2CCCCC2)CC1 InChI=1S/C28H46F3N7O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)37-15-13-35(14-16-37)12-8-7-11-32-26(39)38-19-17-36(18-20-38)22-9-5-4-6-10-22/h21-22H,4-20H2,1-3H3,(H,32,39) GFMAXQNKPHDTKL-UHFFFAOYSA-N 301884 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclohexylpiperazine-1-carboxamide::US9598387, Compound 69::US9969743, 69 D(3) dopamine receptor Human 29.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301884&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669894 381750626 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787731 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C2CCCCC2)CC1 InChI=1S/C28H46F3N7O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)37-15-13-35(14-16-37)12-8-7-11-32-26(39)38-19-17-36(18-20-38)22-9-5-4-6-10-22/h21-22H,4-20H2,1-3H3,(H,32,39) GFMAXQNKPHDTKL-UHFFFAOYSA-N 301884 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclohexylpiperazine-1-carboxamide::US9598387, Compound 69::US9969743, 69 D(2) dopamine receptor Homo sapiens 215 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301884&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669894 381750626 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787732 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCCc3ccccc23)CC1 InChI=1S/C27H37F3N6O/c1-26(2,3)24-32-22(27(28,29)30)19-23(33-24)35-17-15-34(16-18-35)13-7-6-12-31-25(37)36-14-8-10-20-9-4-5-11-21(20)36/h4-5,9,11,19H,6-8,10,12-18H2,1-3H3,(H,31,37) MVXQZFLJPQIVSR-UHFFFAOYSA-N 301885 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3,4-dihydroquinoline-1(2H)-carboxamide::US9598387, Compound 70::US9969743, 70 D(3) dopamine receptor Human 33.5 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301885&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669895 381750627 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787733 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCCc3ccccc23)CC1 InChI=1S/C27H37F3N6O/c1-26(2,3)24-32-22(27(28,29)30)19-23(33-24)35-17-15-34(16-18-35)13-7-6-12-31-25(37)36-14-8-10-20-9-4-5-11-21(20)36/h4-5,9,11,19H,6-8,10,12-18H2,1-3H3,(H,31,37) MVXQZFLJPQIVSR-UHFFFAOYSA-N 301885 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3,4-dihydroquinoline-1(2H)-carboxamide::US9598387, Compound 70::US9969743, 70 D(2) dopamine receptor Homo sapiens 215 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301885&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669895 381750627 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787734 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3ccccc23)CC1 InChI=1S/C26H35F3N6O/c1-25(2,3)23-31-21(26(27,28)29)18-22(32-23)34-16-14-33(15-17-34)12-7-6-11-30-24(36)35-13-10-19-8-4-5-9-20(19)35/h4-5,8-9,18H,6-7,10-17H2,1-3H3,(H,30,36) DZCDJCMQDIXJFE-UHFFFAOYSA-N 301886 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)indoline-1-carboxamide ::US9598387, Compound 71::US9969743, 71 D(3) dopamine receptor Human 27.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301886&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670055 381750628 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787735 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3ccccc23)CC1 InChI=1S/C26H35F3N6O/c1-25(2,3)23-31-21(26(27,28)29)18-22(32-23)34-16-14-33(15-17-34)12-7-6-11-30-24(36)35-13-10-19-8-4-5-9-20(19)35/h4-5,8-9,18H,6-7,10-17H2,1-3H3,(H,30,36) DZCDJCMQDIXJFE-UHFFFAOYSA-N 301886 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)indoline-1-carboxamide ::US9598387, Compound 71::US9969743, 71 D(2) dopamine receptor Homo sapiens 281 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301886&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670055 381750628 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787736 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(Cc3cccc(c3)C#N)CC2)CC1 InChI=1S/C30H41F3N8O/c1-29(2,3)27-36-25(30(31,32)33)20-26(37-27)40-15-11-38(12-16-40)10-5-4-9-35-28(42)41-17-13-39(14-18-41)22-24-8-6-7-23(19-24)21-34/h6-8,19-20H,4-5,9-18,22H2,1-3H3,(H,35,42) OJORGHNUKQKUKG-UHFFFAOYSA-N 301887 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-cyanobenzyl)piperazine-1-carboxamide::US9598387, Compound 72::US9969743, 72 D(3) dopamine receptor Human 84.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301887&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670056 381750629 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787737 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(Cc3cccc(c3)C#N)CC2)CC1 InChI=1S/C30H41F3N8O/c1-29(2,3)27-36-25(30(31,32)33)20-26(37-27)40-15-11-38(12-16-40)10-5-4-9-35-28(42)41-17-13-39(14-18-41)22-24-8-6-7-23(19-24)21-34/h6-8,19-20H,4-5,9-18,22H2,1-3H3,(H,35,42) OJORGHNUKQKUKG-UHFFFAOYSA-N 301887 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(3-cyanobenzyl)piperazine-1-carboxamide::US9598387, Compound 72::US9969743, 72 D(2) dopamine receptor Homo sapiens 820 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301887&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670056 381750629 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787738 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H45ClF3N7O/c1-34(2,3)32-41-29(35(37,38)39)25-30(42-32)44-19-17-43(18-20-44)16-8-7-15-40-33(47)46-23-21-45(22-24-46)31(26-9-5-4-6-10-26)27-11-13-28(36)14-12-27/h4-6,9-14,25,31H,7-8,15-24H2,1-3H3,(H,40,47) MXKOYALXZMWGCQ-UHFFFAOYSA-N 301888 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine-1-carboxamide::US9598387, Compound 73::US9969743, 73 D(3) dopamine receptor Human 130 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301888&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670058 381750630 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787739 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)C(c2ccccc2)c2ccc(Cl)cc2)CC1 InChI=1S/C35H45ClF3N7O/c1-34(2,3)32-41-29(35(37,38)39)25-30(42-32)44-19-17-43(18-20-44)16-8-7-15-40-33(47)46-23-21-45(22-24-46)31(26-9-5-4-6-10-26)27-11-13-28(36)14-12-27/h4-6,9-14,25,31H,7-8,15-24H2,1-3H3,(H,40,47) MXKOYALXZMWGCQ-UHFFFAOYSA-N 301888 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-((4-chlorophenyl)(phenyl)methyl)piperazine-1-carboxamide::US9598387, Compound 73::US9969743, 73 D(2) dopamine receptor Homo sapiens 990 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301888&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670058 381750630 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787740 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC=Cc3ccccc3)CC2)CC1 InChI=1S/C31H44F3N7O/c1-30(2,3)28-36-26(31(32,33)34)24-27(37-28)40-20-16-38(17-21-40)14-8-7-13-35-29(42)41-22-18-39(19-23-41)15-9-12-25-10-5-4-6-11-25/h4-6,9-12,24H,7-8,13-23H2,1-3H3,(H,35,42)/b12-9+ ZEDJJTNDYYFYOC-FMIVXFBMSA-N 301889 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cinnamylpiperazine-1-carboxamide ::US9598387, Compound 74::US9969743, 74 D(3) dopamine receptor Human 66.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301889&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670057 381750631 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787741 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC=Cc3ccccc3)CC2)CC1 InChI=1S/C31H44F3N7O/c1-30(2,3)28-36-26(31(32,33)34)24-27(37-28)40-20-16-38(17-21-40)14-8-7-13-35-29(42)41-22-18-39(19-23-41)15-9-12-25-10-5-4-6-11-25/h4-6,9-12,24H,7-8,13-23H2,1-3H3,(H,35,42)/b12-9+ ZEDJJTNDYYFYOC-FMIVXFBMSA-N 301889 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cinnamylpiperazine-1-carboxamide ::US9598387, Compound 74::US9969743, 74 D(2) dopamine receptor Homo sapiens 585 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301889&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670057 381750631 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787742 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)N2CCCCC2)CC1 InChI=1S/C28H46F3N7O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)37-19-17-35(18-20-37)12-8-5-11-32-26(39)38-15-9-22(10-16-38)36-13-6-4-7-14-36/h21-22H,4-20H2,1-3H3,(H,32,39) SUJGOAOWFMOBBD-UHFFFAOYSA-N 301890 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-[1,4′-bipiperidine]-1′-carboxamide ::US9598387, Compound 75::US9969743, 75 D(3) dopamine receptor Human 9.90 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301890&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670059 381750632 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787743 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(CC2)N2CCCCC2)CC1 InChI=1S/C28H46F3N7O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)37-19-17-35(18-20-37)12-8-5-11-32-26(39)38-15-9-22(10-16-38)36-13-6-4-7-14-36/h21-22H,4-20H2,1-3H3,(H,32,39) SUJGOAOWFMOBBD-UHFFFAOYSA-N 301890 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-[1,4′-bipiperidine]-1′-carboxamide ::US9598387, Compound 75::US9969743, 75 D(2) dopamine receptor Homo sapiens 59.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301890&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670059 381750632 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787744 CN1CCC(CC1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C28H47F3N8O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)38-15-13-36(14-16-38)10-6-5-9-32-26(40)39-19-17-37(18-20-39)22-7-11-35(4)12-8-22/h21-22H,5-20H2,1-4H3,(H,32,40) OGMXPNDTEOMUTP-UHFFFAOYSA-N 301891 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(1-methylpiperidin-4-yl)piperazine-1-carboxamide ::US9598387, Compound 76::US9969743, 76 D(3) dopamine receptor Human 18.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301891&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670219 381750633 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787745 CN1CCC(CC1)N1CCN(CC1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C28H47F3N8O/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)38-15-13-36(14-16-38)10-6-5-9-32-26(40)39-19-17-37(18-20-39)22-7-11-35(4)12-8-22/h21-22H,5-20H2,1-4H3,(H,32,40) OGMXPNDTEOMUTP-UHFFFAOYSA-N 301891 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(1-methylpiperidin-4-yl)piperazine-1-carboxamide ::US9598387, Compound 76::US9969743, 76 D(2) dopamine receptor Homo sapiens 125 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301891&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670219 381750633 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787746 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)S(=O)(=O)c2ccccc2)CC1 InChI=1S/C28H40F3N7O3S/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)36-15-13-35(14-16-36)12-8-7-11-32-26(39)37-17-19-38(20-18-37)42(40,41)22-9-5-4-6-10-22/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,32,39) LJPDJGGEVPZFMY-UHFFFAOYSA-N 301892 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(phenylsulfonyl)piperazine-1-carboxamide ::US9598387, Compound 77::US9969743, 77 D(3) dopamine receptor Human 138 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301892&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670220 381750634 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787747 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2)S(=O)(=O)c2ccccc2)CC1 InChI=1S/C28H40F3N7O3S/c1-27(2,3)25-33-23(28(29,30)31)21-24(34-25)36-15-13-35(14-16-36)12-8-7-11-32-26(39)37-17-19-38(20-18-37)42(40,41)22-9-5-4-6-10-22/h4-6,9-10,21H,7-8,11-20H2,1-3H3,(H,32,39) LJPDJGGEVPZFMY-UHFFFAOYSA-N 301892 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(phenylsulfonyl)piperazine-1-carboxamide ::US9598387, Compound 77::US9969743, 77 D(2) dopamine receptor Homo sapiens 981 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301892&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670220 381750634 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787748 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)S(=O)(=O)c2ccccc2)CC1 InChI=1S/C31H49N7O3S/c1-30(2,3)26-24-27(34-28(33-26)31(4,5)6)36-18-16-35(17-19-36)15-11-10-14-32-29(39)37-20-22-38(23-21-37)42(40,41)25-12-8-7-9-13-25/h7-9,12-13,24H,10-11,14-23H2,1-6H3,(H,32,39) KDBGYTXPYZAGHW-UHFFFAOYSA-N 301893 N-(4-(4-(2,6-Di-tert-butylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-(phenylsulfonyl)piperazine-1-carboxamide::US9598387, Compound 78::US9969743, 78 D(3) dopamine receptor Human 29.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301893&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670221 381750635 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787749 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)S(=O)(=O)c2ccccc2)CC1 InChI=1S/C31H49N7O3S/c1-30(2,3)26-24-27(34-28(33-26)31(4,5)6)36-18-16-35(17-19-36)15-11-10-14-32-29(39)37-20-22-38(23-21-37)42(40,41)25-12-8-7-9-13-25/h7-9,12-13,24H,10-11,14-23H2,1-6H3,(H,32,39) KDBGYTXPYZAGHW-UHFFFAOYSA-N 301893 N-(4-(4-(2,6-Di-tert-butylpyrimidin-4-yl)piperazin-1-yl)butyl)-4-(phenylsulfonyl)piperazine-1-carboxamide::US9598387, Compound 78::US9969743, 78 D(2) dopamine receptor Homo sapiens 448 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301893&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670221 381750635 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787750 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(O)(CC2)c2ccc(Cl)cc2)CC1 InChI=1S/C29H40ClF3N6O2/c1-27(2,3)25-35-23(29(31,32)33)20-24(36-25)38-18-16-37(17-19-38)13-5-4-12-34-26(40)39-14-10-28(41,11-15-39)21-6-8-22(30)9-7-21/h6-9,20,41H,4-5,10-19H2,1-3H3,(H,34,40) KOUYZQIXUIGLHZ-UHFFFAOYSA-N 301894 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-chlorophenyl)-4-hydroxypiperidine-1-carboxamide ::US9598387, Compound 79::US9969743, 79 D(3) dopamine receptor Human 51.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301894&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871038 381750636 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787751 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCC(O)(CC2)c2ccc(Cl)cc2)CC1 InChI=1S/C29H40ClF3N6O2/c1-27(2,3)25-35-23(29(31,32)33)20-24(36-25)38-18-16-37(17-19-38)13-5-4-12-34-26(40)39-14-10-28(41,11-15-39)21-6-8-22(30)9-7-21/h6-9,20,41H,4-5,10-19H2,1-3H3,(H,34,40) KOUYZQIXUIGLHZ-UHFFFAOYSA-N 301894 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-(4-chlorophenyl)-4-hydroxypiperidine-1-carboxamide ::US9598387, Compound 79::US9969743, 79 D(2) dopamine receptor Homo sapiens 834 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301894&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871038 381750636 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787752 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2c2ccccc2)C2CC2)CC1 InChI=1S/C31H44F3N7O/c1-30(2,3)28-36-26(31(32,33)34)21-27(37-28)39-17-15-38(16-18-39)14-8-7-13-35-29(42)41-20-19-40(24-11-12-24)22-25(41)23-9-5-4-6-10-23/h4-6,9-10,21,24-25H,7-8,11-20,22H2,1-3H3,(H,35,42) NBJHQMZILODBNP-UHFFFAOYSA-N 301895 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclopropyl-2-phenylpiperazine-1-carboxamide::US9598387, Compound 80::US9969743, 80 D(3) dopamine receptor Human 118 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301895&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871366 381750637 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787753 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(CC2c2ccccc2)C2CC2)CC1 InChI=1S/C31H44F3N7O/c1-30(2,3)28-36-26(31(32,33)34)21-27(37-28)39-17-15-38(16-18-39)14-8-7-13-35-29(42)41-20-19-40(24-11-12-24)22-25(41)23-9-5-4-6-10-23/h4-6,9-10,21,24-25H,7-8,11-20,22H2,1-3H3,(H,35,42) NBJHQMZILODBNP-UHFFFAOYSA-N 301895 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-cyclopropyl-2-phenylpiperazine-1-carboxamide::US9598387, Compound 80::US9969743, 80 D(2) dopamine receptor Homo sapiens 863 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301895&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871366 381750637 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787754 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCCN(CC2)c2ccccc2)CC1 InChI=1S/C29H42F3N7O/c1-28(2,3)26-34-24(29(30,31)32)22-25(35-26)38-18-16-36(17-19-38)13-8-7-12-33-27(40)39-15-9-14-37(20-21-39)23-10-5-4-6-11-23/h4-6,10-11,22H,7-9,12-21H2,1-3H3,(H,33,40) WUHZLDHICFZBCN-UHFFFAOYSA-N 301896 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenyl-1,4-diazepane-1-carboxamide::US9598387, Compound 81::US9969743, 81 D(3) dopamine receptor Human 44.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301896&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670222 381750638 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787755 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCCN(CC2)c2ccccc2)CC1 InChI=1S/C29H42F3N7O/c1-28(2,3)26-34-24(29(30,31)32)22-25(35-26)38-18-16-36(17-19-38)13-8-7-12-33-27(40)39-15-9-14-37(20-21-39)23-10-5-4-6-11-23/h4-6,10-11,22H,7-9,12-21H2,1-3H3,(H,33,40) WUHZLDHICFZBCN-UHFFFAOYSA-N 301896 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenyl-1,4-diazepane-1-carboxamide::US9598387, Compound 81::US9969743, 81 D(2) dopamine receptor Homo sapiens 507 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301896&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670222 381750638 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787756 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCCC(CC2)c2ccccc2)CC1 InChI=1S/C30H43F3N6O/c1-29(2,3)27-35-25(30(31,32)33)22-26(36-27)38-20-18-37(19-21-38)15-8-7-14-34-28(40)39-16-9-12-24(13-17-39)23-10-5-4-6-11-23/h4-6,10-11,22,24H,7-9,12-21H2,1-3H3,(H,34,40) CQEZTUMTHGCHPH-UHFFFAOYSA-N 301897 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylazepane-1-carboxamide ::US9598387, Compound 82::US9969743, 82 D(3) dopamine receptor Human 129 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301897&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670223 381750639 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787757 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCCC(CC2)c2ccccc2)CC1 InChI=1S/C30H43F3N6O/c1-29(2,3)27-35-25(30(31,32)33)22-26(36-27)38-20-18-37(19-21-38)15-8-7-14-34-28(40)39-16-9-12-24(13-17-39)23-10-5-4-6-11-23/h4-6,10-11,22,24H,7-9,12-21H2,1-3H3,(H,34,40) CQEZTUMTHGCHPH-UHFFFAOYSA-N 301897 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylazepane-1-carboxamide ::US9598387, Compound 82::US9969743, 82 D(2) dopamine receptor Homo sapiens 668 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301897&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670223 381750639 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787758 FC(F)(F)c1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C29H35F3N6O/c30-29(31,32)23-8-9-25-26(22-23)33-12-10-27(25)37-16-14-35(15-17-37)13-5-4-11-34-28(39)38-20-18-36(19-21-38)24-6-2-1-3-7-24/h1-3,6-10,12,22H,4-5,11,13-21H2,(H,34,39) LVLYBVZQVHNPHM-UHFFFAOYSA-N 301898 4-Phenyl-N-(4-(4-(7-(trifluoromethyl)quinolin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 83::US9969743, 83 D(3) dopamine receptor Human 112 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301898&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670395 381750640 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787759 FC(F)(F)c1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C29H35F3N6O/c30-29(31,32)23-8-9-25-26(22-23)33-12-10-27(25)37-16-14-35(15-17-37)13-5-4-11-34-28(39)38-20-18-36(19-21-38)24-6-2-1-3-7-24/h1-3,6-10,12,22H,4-5,11,13-21H2,(H,34,39) LVLYBVZQVHNPHM-UHFFFAOYSA-N 301898 4-Phenyl-N-(4-(4-(7-(trifluoromethyl)quinolin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 83::US9969743, 83 D(2) dopamine receptor Homo sapiens 1550 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301898&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670395 381750640 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787760 O=C(NCCCCN1CCN(CC1)c1ccc2ccccc2n1)N1CCN(CC1)c1ccccc1 InChI=1S/C28H36N6O/c35-28(34-22-20-32(21-23-34)25-9-2-1-3-10-25)29-14-6-7-15-31-16-18-33(19-17-31)27-13-12-24-8-4-5-11-26(24)30-27/h1-5,8-13H,6-7,14-23H2,(H,29,35) GWFPJCOZSBFTOH-UHFFFAOYSA-N 301899 4-Phenyl-N-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 84::US9969743, 84 D(3) dopamine receptor Human 95.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301899&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670396 381750641 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787761 O=C(NCCCCN1CCN(CC1)c1ccc2ccccc2n1)N1CCN(CC1)c1ccccc1 InChI=1S/C28H36N6O/c35-28(34-22-20-32(21-23-34)25-9-2-1-3-10-25)29-14-6-7-15-31-16-18-33(19-17-31)27-13-12-24-8-4-5-11-26(24)30-27/h1-5,8-13H,6-7,14-23H2,(H,29,35) GWFPJCOZSBFTOH-UHFFFAOYSA-N 301899 4-Phenyl-N-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 84::US9969743, 84 D(2) dopamine receptor Homo sapiens 2608 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301899&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670396 381750641 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787762 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)N2CCC(CC2)c2ccccc2)CC1 InChI=1S/C29H36ClN5O/c30-25-8-9-26-27(22-25)31-14-10-28(26)34-20-18-33(19-21-34)15-5-4-13-32-29(36)35-16-11-24(12-17-35)23-6-2-1-3-7-23/h1-3,6-10,14,22,24H,4-5,11-13,15-21H2,(H,32,36) AQKLZOVNXYAGDW-UHFFFAOYSA-N 301900 N-(4-(4-(7-Chloroquinolin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperidine-1-carboxamide::US9598387, Compound 85::US9969743, 85 D(3) dopamine receptor Human 87.9 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301900&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670397 381750642 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787763 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)N2CCC(CC2)c2ccccc2)CC1 InChI=1S/C29H36ClN5O/c30-25-8-9-26-27(22-25)31-14-10-28(26)34-20-18-33(19-21-34)15-5-4-13-32-29(36)35-16-11-24(12-17-35)23-6-2-1-3-7-23/h1-3,6-10,14,22,24H,4-5,11-13,15-21H2,(H,32,36) AQKLZOVNXYAGDW-UHFFFAOYSA-N 301900 N-(4-(4-(7-Chloroquinolin-4-yl)piperazin-1-yl)butyl)-4-phenylpiperidine-1-carboxamide::US9598387, Compound 85::US9969743, 85 D(2) dopamine receptor Homo sapiens 2788 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301900&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670397 381750642 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787764 CC(C)(C)c1cc(cc(c1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C33H51N5O/c1-32(2,3)27-24-28(33(4,5)6)26-30(25-27)37-18-16-35(17-19-37)15-11-10-14-34-31(39)38-22-20-36(21-23-38)29-12-8-7-9-13-29/h7-9,12-13,24-26H,10-11,14-23H2,1-6H3,(H,34,39) OVRUYISKGGXOPK-UHFFFAOYSA-N 301901 N-(4-(4-(3,5-Di-tert-butylphenyl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 86::US9969743, 86 D(3) dopamine receptor Human 110 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301901&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670398 381750643 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787765 CC(C)(C)c1cc(cc(c1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCN(CC2)c2ccccc2)CC1 InChI=1S/C33H51N5O/c1-32(2,3)27-24-28(33(4,5)6)26-30(25-27)37-18-16-35(17-19-37)15-11-10-14-34-31(39)38-22-20-36(21-23-38)29-12-8-7-9-13-29/h7-9,12-13,24-26H,10-11,14-23H2,1-6H3,(H,34,39) OVRUYISKGGXOPK-UHFFFAOYSA-N 301901 N-(4-(4-(3,5-Di-tert-butylphenyl)piperazin-1-yl)butyl)-4-phenylpiperazine-1-carboxamide::US9598387, Compound 86::US9969743, 86 D(2) dopamine receptor Homo sapiens 1849 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301901&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670398 381750643 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787766 Cc1nnc2CN(CCn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C24H36F3N9O/c1-17-31-32-20-16-35(13-14-36(17)20)22(37)28-7-5-6-8-33-9-11-34(12-10-33)19-15-18(24(25,26)27)29-21(30-19)23(2,3)4/h15H,5-14,16H2,1-4H3,(H,28,37) WISDAZOFOXOZSE-UHFFFAOYSA-N 301902 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxamide::US9598387, Compound 87::US9969743, 87 D(3) dopamine receptor Human 28.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301902&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670399 381750644 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787767 Cc1nnc2CN(CCn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C24H36F3N9O/c1-17-31-32-20-16-35(13-14-36(17)20)22(37)28-7-5-6-8-33-9-11-34(12-10-33)19-15-18(24(25,26)27)29-21(30-19)23(2,3)4/h15H,5-14,16H2,1-4H3,(H,28,37) WISDAZOFOXOZSE-UHFFFAOYSA-N 301902 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxamide::US9598387, Compound 87::US9969743, 87 D(2) dopamine receptor Homo sapiens 382 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301902&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670399 381750644 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787768 Cc1nnc2CN(CCn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(C)n1)C(C)(C)C InChI=1S/C24H39N9O/c1-18-26-20(24(3,4)5)16-21(27-18)31-12-10-30(11-13-31)9-7-6-8-25-23(34)32-14-15-33-19(2)28-29-22(33)17-32/h16H,6-15,17H2,1-5H3,(H,25,34) FTLOZRFDKPZXJE-UHFFFAOYSA-N 301903 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxamide::US9598387, Compound 88::US9969743, 88 D(3) dopamine receptor Human 668 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301903&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670564 381750645 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787769 Cc1nnc2CN(CCn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(C)n1)C(C)(C)C InChI=1S/C24H39N9O/c1-18-26-20(24(3,4)5)16-21(27-18)31-12-10-30(11-13-31)9-7-6-8-25-23(34)32-14-15-33-19(2)28-29-22(33)17-32/h16H,6-15,17H2,1-5H3,(H,25,34) FTLOZRFDKPZXJE-UHFFFAOYSA-N 301903 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-3-methyl-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboxamide::US9598387, Compound 88::US9969743, 88 D(2) dopamine receptor Homo sapiens 10541 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301903&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670564 381750645 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787770 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccccc4c3C2)CC1 InChI=1S/C29H38F3N7O/c1-28(2,3)26-35-24(29(30,31)32)18-25(36-26)38-16-14-37(15-17-38)12-7-6-11-33-27(40)39-13-10-23-21(19-39)20-8-4-5-9-22(20)34-23/h4-5,8-9,18,34H,6-7,10-17,19H2,1-3H3,(H,33,40) WCSZBBHBUPLUCU-UHFFFAOYSA-N 301869 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 55::US9598387, Compound 89::US9969743, 89 D(3) dopamine receptor Human 110 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301869&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669386 381750611 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787771 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccccc4c3C2)CC1 InChI=1S/C29H38F3N7O/c1-28(2,3)26-35-24(29(30,31)32)18-25(36-26)38-16-14-37(15-17-38)12-7-6-11-33-27(40)39-13-10-23-21(19-39)20-8-4-5-9-22(20)34-23/h4-5,8-9,18,34H,6-7,10-17,19H2,1-3H3,(H,33,40) WCSZBBHBUPLUCU-UHFFFAOYSA-N 301869 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 55::US9598387, Compound 89::US9969743, 89 D(2) dopamine receptor Homo sapiens 1181 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301869&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73669386 381750611 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787772 Cc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C30H40F3N7O/c1-20-7-8-23-21(17-20)22-19-40(12-9-24(22)35-23)28(41)34-10-5-6-11-38-13-15-39(16-14-38)26-18-25(30(31,32)33)36-27(37-26)29(2,3)4/h7-8,17-18,35H,5-6,9-16,19H2,1-4H3,(H,34,41) WBGCNLMSYUBTIS-UHFFFAOYSA-N 301905 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 90::US9969743, 90 D(3) dopamine receptor Human 128 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301905&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670565 381750646 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787773 Cc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C30H40F3N7O/c1-20-7-8-23-21(17-20)22-19-40(12-9-24(22)35-23)28(41)34-10-5-6-11-38-13-15-39(16-14-38)26-18-25(30(31,32)33)36-27(37-26)29(2,3)4/h7-8,17-18,35H,5-6,9-16,19H2,1-4H3,(H,34,41) WBGCNLMSYUBTIS-UHFFFAOYSA-N 301905 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 90::US9969743, 90 D(2) dopamine receptor Homo sapiens 1341 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301905&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670565 381750646 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787774 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(Cl)cc4c3C2)CC1 InChI=1S/C29H37ClF3N7O/c1-28(2,3)26-36-24(29(31,32)33)17-25(37-26)39-14-12-38(13-15-39)10-5-4-9-34-27(41)40-11-8-23-21(18-40)20-16-19(30)6-7-22(20)35-23/h6-7,16-17,35H,4-5,8-15,18H2,1-3H3,(H,34,41) JQMTWXCZSMHLMS-UHFFFAOYSA-N 301906 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-chloro-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 91::US9969743, 91 D(3) dopamine receptor Human 200 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301906&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670566 381750647 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787775 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(Cl)cc4c3C2)CC1 InChI=1S/C29H37ClF3N7O/c1-28(2,3)26-36-24(29(31,32)33)17-25(37-26)39-14-12-38(13-15-39)10-5-4-9-34-27(41)40-11-8-23-21(18-40)20-16-19(30)6-7-22(20)35-23/h6-7,16-17,35H,4-5,8-15,18H2,1-3H3,(H,34,41) JQMTWXCZSMHLMS-UHFFFAOYSA-N 301906 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-chloro-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 91::US9969743, 91 D(2) dopamine receptor Homo sapiens 1208 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301906&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670566 381750647 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787776 COc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C30H40F3N7O2/c1-29(2,3)27-36-25(30(31,32)33)18-26(37-27)39-15-13-38(14-16-39)11-6-5-10-34-28(41)40-12-9-24-22(19-40)21-17-20(42-4)7-8-23(21)35-24/h7-8,17-18,35H,5-6,9-16,19H2,1-4H3,(H,34,41) MLOKWLKRFPWEHA-UHFFFAOYSA-N 301907 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-methoxy-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 92::US9969743, 92 D(3) dopamine receptor Human 166 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301907&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670567 381750648 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787777 COc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C30H40F3N7O2/c1-29(2,3)27-36-25(30(31,32)33)18-26(37-27)39-15-13-38(14-16-39)11-6-5-10-34-28(41)40-12-9-24-22(19-40)21-17-20(42-4)7-8-23(21)35-24/h7-8,17-18,35H,5-6,9-16,19H2,1-4H3,(H,34,41) MLOKWLKRFPWEHA-UHFFFAOYSA-N 301907 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-8-methoxy-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 92::US9969743, 92 D(2) dopamine receptor Homo sapiens 1352 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301907&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670567 381750648 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787778 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(cc4c3C2)C(F)(F)F)CC1)C(F)F InChI=1S/C30H38F5N7O/c1-29(2,3)27-38-24(26(31)32)17-25(39-27)41-14-12-40(13-15-41)10-5-4-9-36-28(43)42-11-8-23-21(18-42)20-16-19(30(33,34)35)6-7-22(20)37-23/h6-7,16-17,26,37H,4-5,8-15,18H2,1-3H3,(H,36,43) YLULTEDGTZQJDL-UHFFFAOYSA-N 393999 US9969743, 93 D(3) dopamine receptor Human 84.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393999&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146047767 405264111 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787779 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(cc4c3C2)C(F)(F)F)CC1)C(F)F InChI=1S/C30H38F5N7O/c1-29(2,3)27-38-24(26(31)32)17-25(39-27)41-14-12-40(13-15-41)10-5-4-9-36-28(43)42-11-8-23-21(18-42)20-16-19(30(33,34)35)6-7-22(20)37-23/h6-7,16-17,26,37H,4-5,8-15,18H2,1-3H3,(H,36,43) YLULTEDGTZQJDL-UHFFFAOYSA-N 393999 US9969743, 93 D(2) dopamine receptor Homo sapiens 560 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=393999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=393999&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 146047767 405264111 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787780 Cc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(C)n1)C(C)(C)C InChI=1S/C30H43N7O/c1-21-8-9-25-23(18-21)24-20-37(13-10-26(24)34-25)29(38)31-11-6-7-12-35-14-16-36(17-15-35)28-19-27(30(3,4)5)32-22(2)33-28/h8-9,18-19,34H,6-7,10-17,20H2,1-5H3,(H,31,38) PABQRTMOJKZQEP-UHFFFAOYSA-N 301909 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 94::US9969743, 94 D(3) dopamine receptor Human 219 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301909&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670733 381750650 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787781 Cc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(C)n1)C(C)(C)C InChI=1S/C30H43N7O/c1-21-8-9-25-23(18-21)24-20-37(13-10-26(24)34-25)29(38)31-11-6-7-12-35-14-16-36(17-15-35)28-19-27(30(3,4)5)32-22(2)33-28/h8-9,18-19,34H,6-7,10-17,20H2,1-5H3,(H,31,38) PABQRTMOJKZQEP-UHFFFAOYSA-N 301909 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-methyl-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 94::US9969743, 94 D(2) dopamine receptor Homo sapiens 5485 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301909&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670733 381750650 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787782 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(Cl)cc4c3C2)CC1 InChI=1S/C29H40ClN7O/c1-20-32-26(29(2,3)4)18-27(33-20)36-15-13-35(14-16-36)11-6-5-10-31-28(38)37-12-9-25-23(19-37)22-17-21(30)7-8-24(22)34-25/h7-8,17-18,34H,5-6,9-16,19H2,1-4H3,(H,31,38) SNOPKYLYYIIGMF-UHFFFAOYSA-N 301910 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-chloro-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 95::US9969743, 95 D(3) dopamine receptor Human 215 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301910&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670734 381750651 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787783 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(Cl)cc4c3C2)CC1 InChI=1S/C29H40ClN7O/c1-20-32-26(29(2,3)4)18-27(33-20)36-15-13-35(14-16-36)11-6-5-10-31-28(38)37-12-9-25-23(19-37)22-17-21(30)7-8-24(22)34-25/h7-8,17-18,34H,5-6,9-16,19H2,1-4H3,(H,31,38) SNOPKYLYYIIGMF-UHFFFAOYSA-N 301910 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-chloro-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 95::US9969743, 95 D(2) dopamine receptor Homo sapiens 5558 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301910&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670734 381750651 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787784 COc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(C)n1)C(C)(C)C InChI=1S/C30H43N7O2/c1-21-32-27(30(2,3)4)19-28(33-21)36-16-14-35(15-17-36)12-7-6-11-31-29(38)37-13-10-26-24(20-37)23-18-22(39-5)8-9-25(23)34-26/h8-9,18-19,34H,6-7,10-17,20H2,1-5H3,(H,31,38) PWCSMJIRMONKML-UHFFFAOYSA-N 301911 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-methoxy-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 96::US9969743, 96 D(3) dopamine receptor Human 74.9 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301911&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670735 381750652 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787785 COc1ccc2[nH]c3CCN(Cc3c2c1)C(=O)NCCCCN1CCN(CC1)c1cc(nc(C)n1)C(C)(C)C InChI=1S/C30H43N7O2/c1-21-32-27(30(2,3)4)19-28(33-21)36-16-14-35(15-17-36)12-7-6-11-31-29(38)37-13-10-26-24(20-37)23-18-22(39-5)8-9-25(23)34-26/h8-9,18-19,34H,6-7,10-17,20H2,1-5H3,(H,31,38) PWCSMJIRMONKML-UHFFFAOYSA-N 301911 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-methoxy-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide::US9598387, Compound 96::US9969743, 96 D(2) dopamine receptor Homo sapiens >5000 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301911&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670735 381750652 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787786 CC(C)(C)c1cc(cc(c1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1 InChI=1S/C34H49N5O/c1-33(2,3)25-21-26(34(4,5)6)23-27(22-25)38-19-17-37(18-20-38)15-10-9-14-35-32(40)39-16-13-29-28-11-7-8-12-30(28)36-31(29)24-39/h7-8,11-12,21-23,36H,9-10,13-20,24H2,1-6H3,(H,35,40) UKXOUHSVLDNJMD-UHFFFAOYSA-N 394003 US9969743, 97 D(3) dopamine receptor Human 245 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394003&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490690 405264115 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787787 CC(C)(C)c1cc(cc(c1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1 InChI=1S/C34H49N5O/c1-33(2,3)25-21-26(34(4,5)6)23-27(22-25)38-19-17-37(18-20-38)15-10-9-14-35-32(40)39-16-13-29-28-11-7-8-12-30(28)36-31(29)24-39/h7-8,11-12,21-23,36H,9-10,13-20,24H2,1-6H3,(H,35,40) UKXOUHSVLDNJMD-UHFFFAOYSA-N 394003 US9969743, 97 D(2) dopamine receptor Homo sapiens 2440 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394003&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490690 405264115 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787788 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(cc4c3C2)C(F)(F)F)CC1 InChI=1S/C30H40F3N7O/c1-20-35-26(29(2,3)4)18-27(36-20)39-15-13-38(14-16-39)11-6-5-10-34-28(41)40-12-9-25-23(19-40)22-17-21(30(31,32)33)7-8-24(22)37-25/h7-8,17-18,37H,5-6,9-16,19H2,1-4H3,(H,34,41) AXXQKOQTXHLIQM-UHFFFAOYSA-N 301913 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-(trifluoromethyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 98::US9969743, 98 D(3) dopamine receptor Human 1018 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301913&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670736 381750654 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787789 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)N2CCc3[nH]c4ccc(cc4c3C2)C(F)(F)F)CC1 InChI=1S/C30H40F3N7O/c1-20-35-26(29(2,3)4)18-27(36-20)39-15-13-38(14-16-39)11-6-5-10-34-28(41)40-12-9-25-23(19-40)22-17-21(30(31,32)33)7-8-24(22)37-25/h7-8,17-18,37H,5-6,9-16,19H2,1-4H3,(H,34,41) AXXQKOQTXHLIQM-UHFFFAOYSA-N 301913 N-(4-(4-(6-(tert-Butyl)-2-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-8-(trifluoromethyl)-3,4-dihydro-1H-pyrido[4,3-b]indole-2(5H)-carboxamide ::US9598387, Compound 98::US9969743, 98 D(2) dopamine receptor Homo sapiens 6405 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301913&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670736 381750654 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787790 FC(F)(F)c1cc(N2CCN(CCCCNC(=O)N3CCN(CC3)c3ccccc3)CC2)c2ccccc2n1 InChI=1S/C29H35F3N6O/c30-29(31,32)27-22-26(24-10-4-5-11-25(24)34-27)37-16-14-35(15-17-37)13-7-6-12-33-28(39)38-20-18-36(19-21-38)23-8-2-1-3-9-23/h1-5,8-11,22H,6-7,12-21H2,(H,33,39) UFDRKLGFQRVMRE-UHFFFAOYSA-N 301914 4-Phenyl-N-(4-(4-(2-(trifluoromethyl)quinolin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 99::US9969743, 99 D(3) dopamine receptor Human 299 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301914&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670737 381750655 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787791 FC(F)(F)c1cc(N2CCN(CCCCNC(=O)N3CCN(CC3)c3ccccc3)CC2)c2ccccc2n1 InChI=1S/C29H35F3N6O/c30-29(31,32)27-22-26(24-10-4-5-11-25(24)34-27)37-16-14-35(15-17-37)13-7-6-12-33-28(39)38-20-18-36(19-21-38)23-8-2-1-3-9-23/h1-5,8-11,22H,6-7,12-21H2,(H,33,39) UFDRKLGFQRVMRE-UHFFFAOYSA-N 301914 4-Phenyl-N-(4-(4-(2-(trifluoromethyl)quinolin-4-yl)piperazin-1-yl)butyl)piperazine-1-carboxamide::US9598387, Compound 99::US9969743, 99 D(2) dopamine receptor Homo sapiens 7249 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301914&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670737 381750655 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787792 FC(F)(F)c1cc(N2CCN(CCCCNC(=O)N3CCC(CC3)c3ccccc3)CC2)c2ccccc2n1 InChI=1S/C30H36F3N5O/c31-30(32,33)28-22-27(25-10-4-5-11-26(25)35-28)37-20-18-36(19-21-37)15-7-6-14-34-29(39)38-16-12-24(13-17-38)23-8-2-1-3-9-23/h1-5,8-11,22,24H,6-7,12-21H2,(H,34,39) QHJSQVKSJUNYAK-UHFFFAOYSA-N 301915 4-Phenyl-N-(4-(4-(2-(trifluoromethyl)quinolin-4-yl)piperazin-1-yl)butyl)piperidine-1-carboxamide::US9598387, Compound 100::US9969743, 100 D(3) dopamine receptor Human 5318 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301915&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670896 381750656 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787793 FC(F)(F)c1cc(N2CCN(CCCCNC(=O)N3CCC(CC3)c3ccccc3)CC2)c2ccccc2n1 InChI=1S/C30H36F3N5O/c31-30(32,33)28-22-27(25-10-4-5-11-26(25)35-28)37-20-18-36(19-21-37)15-7-6-14-34-29(39)38-16-12-24(13-17-38)23-8-2-1-3-9-23/h1-5,8-11,22,24H,6-7,12-21H2,(H,34,39) QHJSQVKSJUNYAK-UHFFFAOYSA-N 301915 4-Phenyl-N-(4-(4-(2-(trifluoromethyl)quinolin-4-yl)piperazin-1-yl)butyl)piperidine-1-carboxamide::US9598387, Compound 100::US9969743, 100 D(2) dopamine receptor Homo sapiens >100000 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301915&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670896 381750656 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787794 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1)C1CC1 InChI=1S/C31H43N7O/c1-31(2,3)29-34-26(22-10-11-22)20-28(35-29)37-18-16-36(17-19-37)14-7-6-13-32-30(39)38-15-12-24-23-8-4-5-9-25(23)33-27(24)21-38/h4-5,8-9,20,22,33H,6-7,10-19,21H2,1-3H3,(H,32,39) LIXJRDNPUKACMR-UHFFFAOYSA-N 394007 US9969743, 101 D(3) dopamine receptor Human 57.1 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394007&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490689 405264119 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787795 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)N2CCc3c(C2)[nH]c2ccccc32)CC1)C1CC1 InChI=1S/C31H43N7O/c1-31(2,3)29-34-26(22-10-11-22)20-28(35-29)37-18-16-36(17-19-37)14-7-6-13-32-30(39)38-15-12-24-23-8-4-5-9-25(23)33-27(24)21-38/h4-5,8-9,20,22,33H,6-7,10-19,21H2,1-3H3,(H,32,39) LIXJRDNPUKACMR-UHFFFAOYSA-N 394007 US9969743, 101 D(2) dopamine receptor Homo sapiens 789 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=394007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=394007&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 134490689 405264119 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787796 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(C(=O)C2)c2ccccc2)CC1 InChI=1S/C28H38F3N7O2/c1-27(2,3)25-33-22(28(29,30)31)19-23(34-25)36-15-13-35(14-16-36)12-8-7-11-32-26(40)37-17-18-38(24(39)20-37)21-9-5-4-6-10-21/h4-6,9-10,19H,7-8,11-18,20H2,1-3H3,(H,32,40) UGRUVQBETHORJS-UHFFFAOYSA-N 301917 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3-oxo-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 102::US9969743, 102 D(3) dopamine receptor Human 19.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301917&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670898 381750658 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787797 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)N2CCN(C(=O)C2)c2ccccc2)CC1 InChI=1S/C28H38F3N7O2/c1-27(2,3)25-33-22(28(29,30)31)19-23(34-25)36-15-13-35(14-16-36)12-8-7-11-32-26(40)37-17-18-38(24(39)20-37)21-9-5-4-6-10-21/h4-6,9-10,19H,7-8,11-18,20H2,1-3H3,(H,32,40) UGRUVQBETHORJS-UHFFFAOYSA-N 301917 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-3-oxo-4-phenylpiperazine-1-carboxamide ::US9598387, Compound 102::US9969743, 102 D(2) dopamine receptor Homo sapiens 962 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301917&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670898 381750658 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787798 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCC(CC2)c2ccccc2)CC1 InChI=1S/C30H42F3N5O/c1-29(2,3)28-35-25(30(31,32)33)21-26(36-28)38-19-17-37(18-20-38)16-8-7-15-34-27(39)24-13-11-23(12-14-24)22-9-5-4-6-10-22/h4-6,9-10,21,23-24H,7-8,11-20H2,1-3H3,(H,34,39) IHTMZOURUQYLLI-UHFFFAOYSA-N 301918 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylcyclohexanecarboxamide::US9598387, Compound 103::US9969743, 103 D(3) dopamine receptor Human 9.40 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301918&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670899 381750659 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787799 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCC(CC2)c2ccccc2)CC1 InChI=1S/C30H42F3N5O/c1-29(2,3)28-35-25(30(31,32)33)21-26(36-28)38-19-17-37(18-20-38)16-8-7-15-34-27(39)24-13-11-23(12-14-24)22-9-5-4-6-10-22/h4-6,9-10,21,23-24H,7-8,11-20H2,1-3H3,(H,34,39) IHTMZOURUQYLLI-UHFFFAOYSA-N 301918 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-4-phenylcyclohexanecarboxamide::US9598387, Compound 103::US9969743, 103 D(2) dopamine receptor Homo sapiens 1510 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301918&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670899 381750659 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787800 O=C(NCCCCN1CCN(CC1)c1ccnc2ccccc12)C1CCC(CC1)c1ccccc1 InChI=1S/C30H38N4O/c35-30(26-14-12-25(13-15-26)24-8-2-1-3-9-24)32-17-6-7-19-33-20-22-34(23-21-33)29-16-18-31-28-11-5-4-10-27(28)29/h1-5,8-11,16,18,25-26H,6-7,12-15,17,19-23H2,(H,32,35) DSDJYAZONQZKBJ-UHFFFAOYSA-N 301919 4-Phenyl-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)cyclohexanecarboxamide ::US9598387, Compound 104::US9969743, 104 D(3) dopamine receptor Human 35.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301919&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670900 381750660 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787801 O=C(NCCCCN1CCN(CC1)c1ccnc2ccccc12)C1CCC(CC1)c1ccccc1 InChI=1S/C30H38N4O/c35-30(26-14-12-25(13-15-26)24-8-2-1-3-9-24)32-17-6-7-19-33-20-22-34(23-21-33)29-16-18-31-28-11-5-4-10-27(28)29/h1-5,8-11,16,18,25-26H,6-7,12-15,17,19-23H2,(H,32,35) DSDJYAZONQZKBJ-UHFFFAOYSA-N 301919 4-Phenyl-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)cyclohexanecarboxamide ::US9598387, Compound 104::US9969743, 104 D(2) dopamine receptor Homo sapiens 5162 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301919&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73670900 381750660 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787802 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)C2CCC(CC2)c2ccccc2)CC1 InChI=1S/C30H37ClN4O/c31-26-12-13-27-28(22-26)32-16-14-29(27)35-20-18-34(19-21-35)17-5-4-15-33-30(36)25-10-8-24(9-11-25)23-6-2-1-3-7-23/h1-3,6-7,12-14,16,22,24-25H,4-5,8-11,15,17-21H2,(H,33,36) NWRMHPCLJKTXHZ-UHFFFAOYSA-N 301920 N-(4-(4-(7-Chloroquinolin-4-yl)piperazin-1-yl)butyl)-4-phenylcyclohexanecarboxamide::US9598387, Compound 105::US9969743, 105 D(3) dopamine receptor Human 34.5 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301920&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671058 381750661 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787803 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)C2CCC(CC2)c2ccccc2)CC1 InChI=1S/C30H37ClN4O/c31-26-12-13-27-28(22-26)32-16-14-29(27)35-20-18-34(19-21-35)17-5-4-15-33-30(36)25-10-8-24(9-11-25)23-6-2-1-3-7-23/h1-3,6-7,12-14,16,22,24-25H,4-5,8-11,15,17-21H2,(H,33,36) NWRMHPCLJKTXHZ-UHFFFAOYSA-N 301920 N-(4-(4-(7-Chloroquinolin-4-yl)piperazin-1-yl)butyl)-4-phenylcyclohexanecarboxamide::US9598387, Compound 105::US9969743, 105 D(2) dopamine receptor Homo sapiens 1015 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301920&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671058 381750661 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787804 O=C(NCCCCN1CCN(CC1)c1ccc2ccccc2n1)C1CCC(CC1)c1ccccc1 InChI=1S/C30H38N4O/c35-30(27-14-12-25(13-15-27)24-8-2-1-3-9-24)31-18-6-7-19-33-20-22-34(23-21-33)29-17-16-26-10-4-5-11-28(26)32-29/h1-5,8-11,16-17,25,27H,6-7,12-15,18-23H2,(H,31,35) AUOJYDWOWNCBRK-UHFFFAOYSA-N 301921 4-Phenyl-N-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)cyclohexanecarboxamide ::US9598387, Compound 106::US9969743, 106 D(3) dopamine receptor Human 62.0 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301921&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671059 381750662 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787805 O=C(NCCCCN1CCN(CC1)c1ccc2ccccc2n1)C1CCC(CC1)c1ccccc1 InChI=1S/C30H38N4O/c35-30(27-14-12-25(13-15-27)24-8-2-1-3-9-24)31-18-6-7-19-33-20-22-34(23-21-33)29-17-16-26-10-4-5-11-28(26)32-29/h1-5,8-11,16-17,25,27H,6-7,12-15,18-23H2,(H,31,35) AUOJYDWOWNCBRK-UHFFFAOYSA-N 301921 4-Phenyl-N-(4-(4-(quinolin-2-yl)piperazin-1-yl)butyl)cyclohexanecarboxamide ::US9598387, Compound 106::US9969743, 106 D(2) dopamine receptor Homo sapiens 3092 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301921&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671059 381750662 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787806 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)C2CCN(CC2)c2ccc(cn2)C(F)(F)F)CC1 InChI=1S/C29H42F3N7O/c1-21-19-25(36-27(35-21)28(2,3)4)39-17-15-37(16-18-39)12-6-5-11-33-26(40)22-9-13-38(14-10-22)24-8-7-23(20-34-24)29(30,31)32/h7-8,19-20,22H,5-6,9-18H2,1-4H3,(H,33,40) PAAYROHKUKZSEG-UHFFFAOYSA-N 301922 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-1-(5-(trifluoromethyl)pyridin-2-yl)piperidine-4-carboxamide::US9598387, Compound 107::US9969743, 107 D(3) dopamine receptor Human 30.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301922&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671060 381750663 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787807 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)C2CCN(CC2)c2ccc(cn2)C(F)(F)F)CC1 InChI=1S/C29H42F3N7O/c1-21-19-25(36-27(35-21)28(2,3)4)39-17-15-37(16-18-39)12-6-5-11-33-26(40)22-9-13-38(14-10-22)24-8-7-23(20-34-24)29(30,31)32/h7-8,19-20,22H,5-6,9-18H2,1-4H3,(H,33,40) PAAYROHKUKZSEG-UHFFFAOYSA-N 301922 N-(4-(4-(2-(tert-Butyl)-6-methylpyrimidin-4-yl)piperazin-1-yl)butyl)-1-(5-(trifluoromethyl)pyridin-2-yl)piperidine-4-carboxamide::US9598387, Compound 107::US9969743, 107 D(2) dopamine receptor Homo sapiens 970 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301922&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671060 381750663 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787808 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCN(CC2)c2ccccc2)CC1 InChI=1S/C29H41F3N6O/c1-28(2,3)27-34-24(29(30,31)32)21-25(35-27)38-19-17-36(18-20-38)14-8-7-13-33-26(39)22-11-15-37(16-12-22)23-9-5-4-6-10-23/h4-6,9-10,21-22H,7-8,11-20H2,1-3H3,(H,33,39) YFQOPLHEALSEEL-UHFFFAOYSA-N 50057764 CHEMBL3323115::US9598387, Compound 108::US9969743, 108 D(3) dopamine receptor Human 31.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057764&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671061 313070355 CHEMBL3323115 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787809 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCN(CC2)c2ccccc2)CC1 InChI=1S/C29H41F3N6O/c1-28(2,3)27-34-24(29(30,31)32)21-25(35-27)38-19-17-36(18-20-38)14-8-7-13-33-26(39)22-11-15-37(16-12-22)23-9-5-4-6-10-23/h4-6,9-10,21-22H,7-8,11-20H2,1-3H3,(H,33,39) YFQOPLHEALSEEL-UHFFFAOYSA-N 50057764 CHEMBL3323115::US9598387, Compound 108::US9969743, 108 D(2) dopamine receptor Homo sapiens 809 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057764&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671061 313070355 CHEMBL3323115 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787810 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCN(Cc3ccccc3)CC2)CC1 InChI=1S/C30H43F3N6O/c1-29(2,3)28-35-25(30(31,32)33)21-26(36-28)39-19-17-37(18-20-39)14-8-7-13-34-27(40)24-11-15-38(16-12-24)22-23-9-5-4-6-10-23/h4-6,9-10,21,24H,7-8,11-20,22H2,1-3H3,(H,34,40) HIPKZAPXNSTELT-UHFFFAOYSA-N 50057776 CHEMBL3323116::US9598387, Compound 109::US9969743, 109 D(3) dopamine receptor Human 35.6 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057776&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671062 313070367 CHEMBL3323116 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787811 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCN(Cc3ccccc3)CC2)CC1 InChI=1S/C30H43F3N6O/c1-29(2,3)28-35-25(30(31,32)33)21-26(36-28)39-19-17-37(18-20-39)14-8-7-13-34-27(40)24-11-15-38(16-12-24)22-23-9-5-4-6-10-23/h4-6,9-10,21,24H,7-8,11-20,22H2,1-3H3,(H,34,40) HIPKZAPXNSTELT-UHFFFAOYSA-N 50057776 CHEMBL3323116::US9598387, Compound 109::US9969743, 109 D(2) dopamine receptor Homo sapiens 337 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057776&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671062 313070367 CHEMBL3323116 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787812 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCN(CC2)c2ccc(cn2)C(F)(F)F)CC1 InChI=1S/C29H39F6N7O/c1-27(2,3)26-38-22(29(33,34)35)18-24(39-26)42-16-14-40(15-17-42)11-5-4-10-36-25(43)20-8-12-41(13-9-20)23-7-6-21(19-37-23)28(30,31)32/h6-7,18-20H,4-5,8-17H2,1-3H3,(H,36,43) XZMLRFQMXJLGRF-UHFFFAOYSA-N 301925 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-1-(5-(trifluoromethyl)pyridin-2-yl)piperidine-4-carboxamide ::US9598387, Compound 110::US9969743, 110 D(3) dopamine receptor Human 167 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301925&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671215 381750666 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787813 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)C2CCN(CC2)c2ccc(cn2)C(F)(F)F)CC1 InChI=1S/C29H39F6N7O/c1-27(2,3)26-38-22(29(33,34)35)18-24(39-26)42-16-14-40(15-17-42)11-5-4-10-36-25(43)20-8-12-41(13-9-20)23-7-6-21(19-37-23)28(30,31)32/h6-7,18-20H,4-5,8-17H2,1-3H3,(H,36,43) XZMLRFQMXJLGRF-UHFFFAOYSA-N 301925 N-(4-(4-(2-(tert-Butyl)-6-(trifluoromethyl)pyrimidin-4-yl)piperazin-1-yl)butyl)-1-(5-(trifluoromethyl)pyridin-2-yl)piperidine-4-carboxamide ::US9598387, Compound 110::US9969743, 110 D(2) dopamine receptor Homo sapiens 1797 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301925&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671215 381750666 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787814 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H35N7O/c1-19-17-22(29-24(27-19)25(2,3)4)31-15-13-30(14-16-31)11-8-6-10-26-23(33)20-18-32-12-7-5-9-21(32)28-20/h5,7,9,12,17-18H,6,8,10-11,13-16H2,1-4H3,(H,26,33) HWNDEDIZZJRHGF-UHFFFAOYSA-N 50057779 CHEMBL3323008::US9598387, Compound 111::US9969743, 111 D(3) dopamine receptor Human 9.30 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057779&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870490 313070370 CHEMBL3323008 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787815 Cc1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H35N7O/c1-19-17-22(29-24(27-19)25(2,3)4)31-15-13-30(14-16-31)11-8-6-10-26-23(33)20-18-32-12-7-5-9-21(32)28-20/h5,7,9,12,17-18H,6,8,10-11,13-16H2,1-4H3,(H,26,33) HWNDEDIZZJRHGF-UHFFFAOYSA-N 50057779 CHEMBL3323008::US9598387, Compound 111::US9969743, 111 D(2) dopamine receptor Homo sapiens 366 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057779&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870490 313070370 CHEMBL3323008 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787816 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1)C1CC1 InChI=1S/C27H37N7O/c1-27(2,3)26-30-21(20-9-10-20)18-24(31-26)33-16-14-32(15-17-33)12-7-5-11-28-25(35)22-19-34-13-6-4-8-23(34)29-22/h4,6,8,13,18-20H,5,7,9-12,14-17H2,1-3H3,(H,28,35) QSQIAXNZWRLSSO-UHFFFAOYSA-N 50057777 CHEMBL3323010::US9598387, Compound 112::US9969743, 112 D(3) dopamine receptor Human 8.40 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057777&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871054 313070368 CHEMBL3323010 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787817 CC(C)(C)c1nc(cc(n1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1)C1CC1 InChI=1S/C27H37N7O/c1-27(2,3)26-30-21(20-9-10-20)18-24(31-26)33-16-14-32(15-17-33)12-7-5-11-28-25(35)22-19-34-13-6-4-8-23(34)29-22/h4,6,8,13,18-20H,5,7,9-12,14-17H2,1-3H3,(H,28,35) QSQIAXNZWRLSSO-UHFFFAOYSA-N 50057777 CHEMBL3323010::US9598387, Compound 112::US9969743, 112 D(2) dopamine receptor Homo sapiens 191 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057777&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871054 313070368 CHEMBL3323010 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787818 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H32F3N7O/c1-24(2,3)23-31-19(25(26,27)28)16-21(32-23)34-14-12-33(13-15-34)10-7-5-9-29-22(36)18-17-35-11-6-4-8-20(35)30-18/h4,6,8,11,16-17H,5,7,9-10,12-15H2,1-3H3,(H,29,36) MGDSRFOVDPARJD-UHFFFAOYSA-N 50057762 CHEMBL3323011::US9598387, Compound 113::US9969743, 113 D(3) dopamine receptor Human 4.20 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057762&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 66574145 313070353 CHEMBL3323011 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787819 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H32F3N7O/c1-24(2,3)23-31-19(25(26,27)28)16-21(32-23)34-14-12-33(13-15-34)10-7-5-9-29-22(36)18-17-35-11-6-4-8-20(35)30-18/h4,6,8,11,16-17H,5,7,9-10,12-15H2,1-3H3,(H,29,36) MGDSRFOVDPARJD-UHFFFAOYSA-N 50057762 CHEMBL3323011::US9598387, Compound 113::US9969743, 113 D(2) dopamine receptor Homo sapiens 511 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057762&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 66574145 313070353 CHEMBL3323011 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787820 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3cccnc3n2)CC1 InChI=1S/C24H31F3N8O/c1-23(2,3)21-31-18(24(25,26)27)15-19(32-21)34-13-11-33(12-14-34)9-5-4-7-28-20(36)17-16-35-10-6-8-29-22(35)30-17/h6,8,10,15-16H,4-5,7,9,11-14H2,1-3H3,(H,28,36) RJRFHPUWQFNLFN-UHFFFAOYSA-N 50057768 CHEMBL3323015::US9598387, Compound 114::US9969743, 114 D(3) dopamine receptor Human 11.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057768&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671216 313070359 CHEMBL3323015 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787821 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3cccnc3n2)CC1 InChI=1S/C24H31F3N8O/c1-23(2,3)21-31-18(24(25,26)27)15-19(32-21)34-13-11-33(12-14-34)9-5-4-7-28-20(36)17-16-35-10-6-8-29-22(35)30-17/h6,8,10,15-16H,4-5,7,9,11-14H2,1-3H3,(H,28,36) RJRFHPUWQFNLFN-UHFFFAOYSA-N 50057768 CHEMBL3323015::US9598387, Compound 114::US9969743, 114 D(2) dopamine receptor Homo sapiens 436 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057768&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671216 313070359 CHEMBL3323015 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787822 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3ccncc3n2)CC1 InChI=1S/C24H31F3N8O/c1-23(2,3)22-31-18(24(25,26)27)14-19(32-22)34-12-10-33(11-13-34)8-5-4-6-29-21(36)17-16-35-9-7-28-15-20(35)30-17/h7,9,14-16H,4-6,8,10-13H2,1-3H3,(H,29,36) VRHJRFPPAACNSV-UHFFFAOYSA-N 50057763 CHEMBL3323016::US9598387, Compound 115::US9969743, 115 D(3) dopamine receptor Human 8.00 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057763&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671217 313070354 CHEMBL3323016 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787823 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3ccncc3n2)CC1 InChI=1S/C24H31F3N8O/c1-23(2,3)22-31-18(24(25,26)27)14-19(32-22)34-12-10-33(11-13-34)8-5-4-6-29-21(36)17-16-35-9-7-28-15-20(35)30-17/h7,9,14-16H,4-6,8,10-13H2,1-3H3,(H,29,36) VRHJRFPPAACNSV-UHFFFAOYSA-N 50057763 CHEMBL3323016::US9598387, Compound 115::US9969743, 115 D(2) dopamine receptor Homo sapiens 450 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057763&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671217 313070354 CHEMBL3323016 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787824 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3nc(Cl)ccc3n2)CC1 InChI=1S/C24H30ClF3N8O/c1-23(2,3)22-31-17(24(26,27)28)14-20(32-22)35-12-10-34(11-13-35)9-5-4-8-29-21(37)16-15-36-19(30-16)7-6-18(25)33-36/h6-7,14-15H,4-5,8-13H2,1-3H3,(H,29,37) VCZAICHKRVTUHW-UHFFFAOYSA-N 50057767 CHEMBL3323017::US9598387, Compound 116::US9969743, 116 D(3) dopamine receptor Human 10.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057767&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671218 313070358 CHEMBL3323017 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787825 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3nc(Cl)ccc3n2)CC1 InChI=1S/C24H30ClF3N8O/c1-23(2,3)22-31-17(24(26,27)28)14-20(32-22)35-12-10-34(11-13-35)9-5-4-8-29-21(37)16-15-36-19(30-16)7-6-18(25)33-36/h6-7,14-15H,4-5,8-13H2,1-3H3,(H,29,37) VCZAICHKRVTUHW-UHFFFAOYSA-N 50057767 CHEMBL3323017::US9598387, Compound 116::US9969743, 116 D(2) dopamine receptor Homo sapiens 655 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057767&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671218 313070358 CHEMBL3323017 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787826 O=C(NCCCCN1CCN(CC1)c1ccnc2ccccc12)c1cn2ccccc2n1 InChI=1S/C25H28N6O/c32-25(22-19-31-14-5-3-9-24(31)28-22)27-11-4-6-13-29-15-17-30(18-16-29)23-10-12-26-21-8-2-1-7-20(21)23/h1-3,5,7-10,12,14,19H,4,6,11,13,15-18H2,(H,27,32) OWKWAFZWCZQWNM-UHFFFAOYSA-N 50057774 CHEMBL3322998::US9598387, Compound 117::US9969743, 117 D(3) dopamine receptor Human 20.5 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057774&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671219 313070365 CHEMBL3322998 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787827 O=C(NCCCCN1CCN(CC1)c1ccnc2ccccc12)c1cn2ccccc2n1 InChI=1S/C25H28N6O/c32-25(22-19-31-14-5-3-9-24(31)28-22)27-11-4-6-13-29-15-17-30(18-16-29)23-10-12-26-21-8-2-1-7-20(21)23/h1-3,5,7-10,12,14,19H,4,6,11,13,15-18H2,(H,27,32) OWKWAFZWCZQWNM-UHFFFAOYSA-N 50057774 CHEMBL3322998::US9598387, Compound 117::US9969743, 117 D(2) dopamine receptor Homo sapiens 572 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057774&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671219 313070365 CHEMBL3322998 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787828 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H27ClN6O/c26-19-6-7-20-21(17-19)27-10-8-23(20)31-15-13-30(14-16-31)11-4-2-9-28-25(33)22-18-32-12-3-1-5-24(32)29-22/h1,3,5-8,10,12,17-18H,2,4,9,11,13-16H2,(H,28,33) NWVMEGNJSPJMDY-UHFFFAOYSA-N 50057785 CHEMBL3323001::US9598387, Compound 118::US9969743, 118 D(3) dopamine receptor Human 28.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057785&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671367 313070376 CHEMBL3323001 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787829 Clc1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H27ClN6O/c26-19-6-7-20-21(17-19)27-10-8-23(20)31-15-13-30(14-16-31)11-4-2-9-28-25(33)22-18-32-12-3-1-5-24(32)29-22/h1,3,5-8,10,12,17-18H,2,4,9,11,13-16H2,(H,28,33) NWVMEGNJSPJMDY-UHFFFAOYSA-N 50057785 CHEMBL3323001::US9598387, Compound 118::US9969743, 118 D(2) dopamine receptor Homo sapiens 1883 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057785&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 73671367 313070376 CHEMBL3323001 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787830 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3c(CO)cccc3n2)CC1 InChI=1S/C26H34F3N7O2/c1-25(2,3)24-32-20(26(27,28)29)15-22(33-24)35-13-11-34(12-14-35)10-5-4-9-30-23(38)19-16-36-18(17-37)7-6-8-21(36)31-19/h6-8,15-16,37H,4-5,9-14,17H2,1-3H3,(H,30,38) JFDSONZAQMFHCW-UHFFFAOYSA-N 50057765 CHEMBL3323113::US9598387, Compound 119::US9969743, 119 D(3) dopamine receptor Human 45.4 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057765&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870976 313070356 CHEMBL3323113 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787831 CC(C)(C)c1nc(cc(n1)C(F)(F)F)N1CCN(CCCCNC(=O)c2cn3c(CO)cccc3n2)CC1 InChI=1S/C26H34F3N7O2/c1-25(2,3)24-32-20(26(27,28)29)15-22(33-24)35-13-11-34(12-14-35)10-5-4-9-30-23(38)19-16-36-18(17-37)7-6-8-21(36)31-19/h6-8,15-16,37H,4-5,9-14,17H2,1-3H3,(H,30,38) JFDSONZAQMFHCW-UHFFFAOYSA-N 50057765 CHEMBL3323113::US9598387, Compound 119::US9969743, 119 D(2) dopamine receptor Homo sapiens 934 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057765&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870976 313070356 CHEMBL3323113 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787832 CN(C)Cc1c(nc2ccccn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C28H39F3N8O/c1-27(2,3)26-33-21(28(29,30)31)18-23(35-26)38-16-14-37(15-17-38)12-9-7-11-32-25(40)24-20(19-36(4)5)39-13-8-6-10-22(39)34-24/h6,8,10,13,18H,7,9,11-12,14-17,19H2,1-5H3,(H,32,40) WMXFRQFMQHQCBJ-UHFFFAOYSA-N 50057753 CHEMBL3323112::US9598387, Compound 120::US9969743, 120 D(3) dopamine receptor Human 28.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057753&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871069 103953775 CHEMBL3323112 ZINC40723347 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787833 CN(C)Cc1c(nc2ccccn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C28H39F3N8O/c1-27(2,3)26-33-21(28(29,30)31)18-23(35-26)38-16-14-37(15-17-38)12-9-7-11-32-25(40)24-20(19-36(4)5)39-13-8-6-10-22(39)34-24/h6,8,10,13,18H,7,9,11-12,14-17,19H2,1-5H3,(H,32,40) WMXFRQFMQHQCBJ-UHFFFAOYSA-N 50057753 CHEMBL3323112::US9598387, Compound 120::US9969743, 120 D(2) dopamine receptor Homo sapiens 301 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057753&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871069 103953775 CHEMBL3323112 ZINC40723347 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787834 CN(C)Cc1cccc2nc(cn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C28H39F3N8O/c1-27(2,3)26-34-22(28(29,30)31)17-24(35-26)38-15-13-37(14-16-38)12-7-6-11-32-25(40)21-19-39-20(18-36(4)5)9-8-10-23(39)33-21/h8-10,17,19H,6-7,11-16,18H2,1-5H3,(H,32,40) JUJJUAKPUFHLKF-UHFFFAOYSA-N 50057757 CHEMBL3323114::US9598387, Compound 121::US9969743, 121 D(3) dopamine receptor Human 27.3 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057757&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870140 103953779 CHEMBL3323114 ZINC04664764 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787835 CN(C)Cc1cccc2nc(cn12)C(=O)NCCCCN1CCN(CC1)c1cc(nc(n1)C(C)(C)C)C(F)(F)F InChI=1S/C28H39F3N8O/c1-27(2,3)26-34-22(28(29,30)31)17-24(35-26)38-15-13-37(14-16-38)12-7-6-11-32-25(40)21-19-39-20(18-36(4)5)9-8-10-23(39)33-21/h8-10,17,19H,6-7,11-16,18H2,1-5H3,(H,32,40) JUJJUAKPUFHLKF-UHFFFAOYSA-N 50057757 CHEMBL3323114::US9598387, Compound 121::US9969743, 121 D(2) dopamine receptor Homo sapiens 298 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057757&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870140 103953779 CHEMBL3323114 ZINC04664764 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787836 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C28H41N7O/c1-27(2,3)22-19-24(32-26(31-22)28(4,5)6)34-17-15-33(16-18-34)13-10-8-12-29-25(36)21-20-35-14-9-7-11-23(35)30-21/h7,9,11,14,19-20H,8,10,12-13,15-18H2,1-6H3,(H,29,36) BSVRQWRWWJQETN-UHFFFAOYSA-N 50057778 CHEMBL3323009::US9598387, Compound 122::US9969743, 122 D(3) dopamine receptor Human 18.8 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057778&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870408 313070369 CHEMBL3323009 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787837 CC(C)(C)c1cc(nc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C28H41N7O/c1-27(2,3)22-19-24(32-26(31-22)28(4,5)6)34-17-15-33(16-18-34)13-10-8-12-29-25(36)21-20-35-14-9-7-11-23(35)30-21/h7,9,11,14,19-20H,8,10,12-13,15-18H2,1-6H3,(H,29,36) BSVRQWRWWJQETN-UHFFFAOYSA-N 50057778 CHEMBL3323009::US9598387, Compound 122::US9969743, 122 D(2) dopamine receptor Homo sapiens 361 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057778&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870408 313070369 CHEMBL3323009 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787838 CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c2ccccc2n1 InChI=1S/C28H35N7O/c1-28(2,3)27-31-22-11-5-4-10-21(22)25(32-27)34-18-16-33(17-19-34)14-9-7-13-29-26(36)23-20-35-15-8-6-12-24(35)30-23/h4-6,8,10-12,15,20H,7,9,13-14,16-19H2,1-3H3,(H,29,36) FQJVIZLZSFQUTO-UHFFFAOYSA-N 50057783 CHEMBL3323004::US9598387, Compound 123::US9969743, 123 D(3) dopamine receptor Human 78.2 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057783&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871083 313070374 CHEMBL3323004 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787839 CC(C)(C)c1nc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c2ccccc2n1 InChI=1S/C28H35N7O/c1-28(2,3)27-31-22-11-5-4-10-21(22)25(32-27)34-18-16-33(17-19-34)14-9-7-13-29-26(36)23-20-35-15-8-6-12-24(35)30-23/h4-6,8,10-12,15,20H,7,9,13-14,16-19H2,1-3H3,(H,29,36) FQJVIZLZSFQUTO-UHFFFAOYSA-N 50057783 CHEMBL3323004::US9598387, Compound 123::US9969743, 123 D(2) dopamine receptor Homo sapiens 1452 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057783&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871083 313070374 CHEMBL3323004 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787840 FC(F)(F)c1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C26H27F3N6O/c27-26(28,29)19-6-7-20-21(17-19)30-10-8-23(20)34-15-13-33(14-16-34)11-4-2-9-31-25(36)22-18-35-12-3-1-5-24(35)32-22/h1,3,5-8,10,12,17-18H,2,4,9,11,13-16H2,(H,31,36) HZTKYJRCVZENNH-UHFFFAOYSA-N 50057786 CHEMBL3323000::US9598387, Compound 124::US9969743, 124 D(3) dopamine receptor Human 98.7 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057786&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870915 313070377 CHEMBL3323000 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787841 FC(F)(F)c1ccc2c(ccnc2c1)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C26H27F3N6O/c27-26(28,29)19-6-7-20-21(17-19)30-10-8-23(20)34-15-13-33(14-16-34)11-4-2-9-31-25(36)22-18-35-12-3-1-5-24(35)32-22/h1,3,5-8,10,12,17-18H,2,4,9,11,13-16H2,(H,31,36) HZTKYJRCVZENNH-UHFFFAOYSA-N 50057786 CHEMBL3323000::US9598387, Compound 124::US9969743, 124 D(2) dopamine receptor Homo sapiens 4983 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057786&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870915 313070377 CHEMBL3323000 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787842 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H35N7O/c1-19-27-21(25(2,3)4)17-23(28-19)31-15-13-30(14-16-31)11-8-6-10-26-24(33)20-18-32-12-7-5-9-22(32)29-20/h5,7,9,12,17-18H,6,8,10-11,13-16H2,1-4H3,(H,26,33) MQWDTDMXDZXQGS-UHFFFAOYSA-N 50057780 CHEMBL3323007::US9598387, Compound 125::US9969743, 125 D(3) dopamine receptor Human 134 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057780&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870714 313070371 CHEMBL3323007 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787843 Cc1nc(cc(n1)C(C)(C)C)N1CCN(CCCCNC(=O)c2cn3ccccc3n2)CC1 InChI=1S/C25H35N7O/c1-19-27-21(25(2,3)4)17-23(28-19)31-15-13-30(14-16-31)11-8-6-10-26-24(33)20-18-32-12-7-5-9-22(32)29-20/h5,7,9,12,17-18H,6,8,10-11,13-16H2,1-4H3,(H,26,33) MQWDTDMXDZXQGS-UHFFFAOYSA-N 50057780 CHEMBL3323007::US9598387, Compound 125::US9969743, 125 D(2) dopamine receptor Homo sapiens 4604 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057780&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870714 313070371 CHEMBL3323007 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787844 O=C(NCCCCN1CCN(CC1)c1ccc2ccccc2n1)c1cn2cccnc2n1 InChI=1S/C24H27N7O/c32-23(21-18-31-13-5-11-26-24(31)28-21)25-10-3-4-12-29-14-16-30(17-15-29)22-9-8-19-6-1-2-7-20(19)27-22/h1-2,5-9,11,13,18H,3-4,10,12,14-17H2,(H,25,32) XYAFTCLJGUGMBU-UHFFFAOYSA-N 301941 N-(4-(4-(Quinolin-2-yl)piperazin-1-yl)butyl)imidazo[1,2-a]pyrimidine-2-carboxamide ::US9598387, Compound 126::US9969743, 126 D(3) dopamine receptor Human 161 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301941&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871439 381750682 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787845 O=C(NCCCCN1CCN(CC1)c1ccc2ccccc2n1)c1cn2cccnc2n1 InChI=1S/C24H27N7O/c32-23(21-18-31-13-5-11-26-24(31)28-21)25-10-3-4-12-29-14-16-30(17-15-29)22-9-8-19-6-1-2-7-20(19)27-22/h1-2,5-9,11,13,18H,3-4,10,12,14-17H2,(H,25,32) XYAFTCLJGUGMBU-UHFFFAOYSA-N 301941 N-(4-(4-(Quinolin-2-yl)piperazin-1-yl)butyl)imidazo[1,2-a]pyrimidine-2-carboxamide ::US9598387, Compound 126::US9969743, 126 D(2) dopamine receptor Homo sapiens 1260 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301941&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871439 381750682 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787846 O=C(NCCCCN1CCN(CC1)c1ncnc2ccccc12)c1cn2ccccc2n1 InChI=1S/C24H27N7O/c32-24(21-17-31-12-5-3-9-22(31)28-21)25-10-4-6-11-29-13-15-30(16-14-29)23-19-7-1-2-8-20(19)26-18-27-23/h1-3,5,7-9,12,17-18H,4,6,10-11,13-16H2,(H,25,32) HISGEOZMKTZBBP-UHFFFAOYSA-N 50057775 CHEMBL3323003::US9598387, Compound 127::US9969743, 127 D(3) dopamine receptor Human 253 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057775&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117869686 313070366 CHEMBL3323003 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787847 O=C(NCCCCN1CCN(CC1)c1ncnc2ccccc12)c1cn2ccccc2n1 InChI=1S/C24H27N7O/c32-24(21-17-31-12-5-3-9-22(31)28-21)25-10-4-6-11-29-13-15-30(16-14-29)23-19-7-1-2-8-20(19)26-18-27-23/h1-3,5,7-9,12,17-18H,4,6,10-11,13-16H2,(H,25,32) HISGEOZMKTZBBP-UHFFFAOYSA-N 50057775 CHEMBL3323003::US9598387, Compound 127::US9969743, 127 D(2) dopamine receptor Homo sapiens 1133 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057775&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117869686 313070366 CHEMBL3323003 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787848 Brc1c(nc2ccccn12)C(=O)NCCCCN1CCN(CC1)c1ccnc2ccccc12 InChI=1S/C25H27BrN6O/c26-24-23(29-22-9-3-5-14-32(22)24)25(33)28-11-4-6-13-30-15-17-31(18-16-30)21-10-12-27-20-8-2-1-7-19(20)21/h1-3,5,7-10,12,14H,4,6,11,13,15-18H2,(H,28,33) JIPGSTBSUISSPJ-UHFFFAOYSA-N 301943 3-Bromo-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)imidazo[1,2-a]pyridine-2-carboxamide::US9598387, Compound 128::US9969743, 128 D(3) dopamine receptor Human 285 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301943&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870916 381750684 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787849 Brc1c(nc2ccccn12)C(=O)NCCCCN1CCN(CC1)c1ccnc2ccccc12 InChI=1S/C25H27BrN6O/c26-24-23(29-22-9-3-5-14-32(22)24)25(33)28-11-4-6-13-30-15-17-31(18-16-30)21-10-12-27-20-8-2-1-7-19(20)21/h1-3,5,7-10,12,14H,4,6,11,13,15-18H2,(H,28,33) JIPGSTBSUISSPJ-UHFFFAOYSA-N 301943 3-Bromo-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)imidazo[1,2-a]pyridine-2-carboxamide::US9598387, Compound 128::US9969743, 128 D(2) dopamine receptor Homo sapiens 2331 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301943&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870916 381750684 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787850 Clc1c(nc2ccccn12)C(=O)NCCCCN1CCN(CC1)c1ccnc2ccccc12 InChI=1S/C25H27ClN6O/c26-24-23(29-22-9-3-5-14-32(22)24)25(33)28-11-4-6-13-30-15-17-31(18-16-30)21-10-12-27-20-8-2-1-7-19(20)21/h1-3,5,7-10,12,14H,4,6,11,13,15-18H2,(H,28,33) WCEIUAYVTGWLJR-UHFFFAOYSA-N 301944 3-Chloro-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)imidazo[1,2-a]pyridine-2-carboxamide::US9598387, Compound 129::US9969743, 129 D(3) dopamine receptor Human 323 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301944&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871045 381750685 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787851 Clc1c(nc2ccccn12)C(=O)NCCCCN1CCN(CC1)c1ccnc2ccccc12 InChI=1S/C25H27ClN6O/c26-24-23(29-22-9-3-5-14-32(22)24)25(33)28-11-4-6-13-30-15-17-31(18-16-30)21-10-12-27-20-8-2-1-7-19(20)21/h1-3,5,7-10,12,14H,4,6,11,13,15-18H2,(H,28,33) WCEIUAYVTGWLJR-UHFFFAOYSA-N 301944 3-Chloro-N-(4-(4-(quinolin-4-yl)piperazin-1-yl)butyl)imidazo[1,2-a]pyridine-2-carboxamide::US9598387, Compound 129::US9969743, 129 D(2) dopamine receptor Homo sapiens 3561 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=301944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=301944&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117871045 381750685 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9 787852 FC(F)(F)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c2ccccc2n1 InChI=1S/C26H27F3N6O/c27-26(28,29)23-17-22(19-7-1-2-8-20(19)31-23)34-15-13-33(14-16-34)11-6-4-10-30-25(36)21-18-35-12-5-3-9-24(35)32-21/h1-3,5,7-9,12,17-18H,4,6,10-11,13-16H2,(H,30,36) SJNLUIGGLBDGFM-UHFFFAOYSA-N 50057787 CHEMBL3322999::US9598387, Compound 130::US9969743, 130 D(3) dopamine receptor Human 524 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=489&target=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057787&enzyme=D%283%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870413 313070378 CHEMBL3322999 1 MASLSQLSSHLNYTCGAENSTGASQARPHAYYALSYCALILAIVFGNGLVCMAVLKERALQTTTNYLVVSLAVADLLVATLVMPWVVYLEVTGGVWNFSRICCDVFVTLDVMMCTASILNLCAISIDRYTAVVMPVHYQHGTGQSSCRRVALMITAVWVLAFAVSCPLLFGFNTTGDPTVCSISNPDFVIYSSVVSFYLPFGVTVLVYARIYVVLKQRRRKRILTRQNSQCNSVRPGFPQQTLSPDPAHLELKRYYSICQDTALGGPGFQERGGELKREEKTRNSLSPTIAPKLSLEVRKLSNGRLSTSLKLGPLQPRGVPLREKKATQMVAIVLGAFIVCWLPFFLTHVLNTHCQTCHVSPELYSATTWLGYVNSALNPVIYTTFNIEFRKAFLKILSC 7CMU,7CMV,8IRT D(3) dopamine receptor DRD3_HUMAN P35462 A1A4V5 Q4VBM8 787853 FC(F)(F)c1cc(N2CCN(CCCCNC(=O)c3cn4ccccc4n3)CC2)c2ccccc2n1 InChI=1S/C26H27F3N6O/c27-26(28,29)23-17-22(19-7-1-2-8-20(19)31-23)34-15-13-33(14-16-34)11-6-4-10-30-25(36)21-18-35-12-5-3-9-24(35)32-21/h1-3,5,7-9,12,17-18H,4,6,10-11,13-16H2,(H,30,36) SJNLUIGGLBDGFM-UHFFFAOYSA-N 50057787 CHEMBL3322999::US9598387, Compound 130::US9969743, 130 D(2) dopamine receptor Homo sapiens 13567 US Patent 10.7270/Q2HD7Z0N aid1798974 US9969743 Ananthan, S 5/15/2018 4/6/2020 Southern Research Institute http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50057787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5866&target=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50057787&enzyme=D%282%29+dopamine+receptor&column=ki&startPg=0&Increment=50&submit=Search 117870413 313070378 CHEMBL3322999 1 MDPLNLSWYDDDLERQNWSRPFNGSDGKADRPHYNYYATLLTLLIAVIVFGNVLVCMAVSREKALQTTTNYLIVSLAVADLLVATLVMPWVVYLEVVGEWKFSRIHCDIFVTLDVMMCTASILNLCAISIDRYTAVAMPMLYNTRYSSKRRVTVMISIVWVLSFTISCPLLFGLNNADQNECIIANPAFVVYSSIVSFYVPFIVTLLVYIKIYIVLRRRRKRVNTKRSSRAFRAHLRAPLKGNCTHPEDMKLCTVIMKSNGSFPVNRRRVEAARRAQELEMEMLSSTSPPERTRYSPIPPSHHQLTLPDPSHHGLHSTPDSPAKPEKNGHAKDHPKIAKIFEIQTMPNGKTRTSLKTMSRRKLSQQKEKKATQMLAIVLGVFIICWLPFFITHILNIHCDCNIPPVLYSAFTWLGYVNSAVNPIIYTTFNIEFRKAFLKILHC 7JVR,8IRS D(2) dopamine receptor DRD2_HUMAN P14416 Q9NZR3 Q9UPA9